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WILLIAM W. ENGSTROM
The development of methods whereby assays of certain groups of
steroid substances in urine can be rather easily and accurately carried
out has advanced our understanding of the role played by the steroid
hormones in physiologic processes. Beside the usual procedures of
chemical and biological assay, additional information has been afforded
by the laborious isolation and characterization of the crystalline steroids
that are excreted in human urine. This report will be a survey of data
regarding the nature, amounts, and possible significance of the neutral
urinary steroids in normal and in abnormal clinical states. With the
present state of information in this field it is easy to surround oneself
with a jungle of facts but more difficult to emerge with real knowledge;
hence, as much emphasis will be placed on the limited applicability of
the data and methods as on their value in the diagnosis and interpreta-
tion of disease processes. The importance of chemical investigations
cannot be depreciated, but one must always return to the biological
level for appraisal of the findings. Extensive and valuable animal ex-
perimentation has been carried out in an effort to understand the r6le
played by the steroids in the organism. Although a review of these
data is beyond the scope of this report and can be found elsewhere,
certain biological principles derived from this information cannot be
disregarded when endeavoring to interpret certain findings in man.
Further, it will be necessary to consider briefly the possible origins and
nature of those substances which give rise to the excretory products,
since assays of the latter are possibly only indirect measures of com-
pounds active in the body. Also, to visualize accurately the various
groups of steroid substances that are excreted it is necessary to know the
methods which are used to separate one group from another and how
the quantitative or qualitative composition of each group is determined.
Efforts will be made to summarize and organize the data so that they
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will be intelligible to those not well acquainted with the subject; how-
ever, it is neither wise nor possible to simplify the complexities of the
field. This becomes apparent when one is forced to interpret the results
of an assay procedure in the light of much uncertain knowledge re-
gardingprecisemechanismsofhormone formation, secretion, and action.
Orientationregardingterminology andformulae
The manner
inwhichthecar-
bon atoms and
rings of the
nucleus are
H numbered and
ETIOCHOLAME (19 CARbON Atoms) ANDROSTANE designated is
given in Fig. 1.
'21 c Many neutral
steroidshave the
basic androstane c4c.cvz9~ or etiocholane
type of con-
figuration, the
PRECNAN6 (21 CARt.ort ATOMS) ALLO-PREONAaN difference be- tween the two
FIG. 1. Structural chamaeristics of certain fundamental steroids. being the differ-
ence in spatial
position of the hydrogen atom at C-5. Also, it will be noted that when
an etiocholane is substituted with a CH3CH2-group at C-17 it is
designated as a pregnane; a similarly substituted androstane is known
as an allo-pregnane. Therefore' when it is stated, for example, that a
compound is a "pregnane" or an "androstane," the nuclear structure of
the compound or its derivative is indicated and also whether or not
the two-carbon side chain is present at C-17. So much for the basic
structure.
Examination of the natural steroids reveals, however, that they may
have attached hydroxyl or ketone groups and frequently possess a
double bond in the nucleus. When a ketone group is present it is
sufficient merely to state at which carbon atom the group occurs, as
17-keto-androstane. More frequently, however, it is customary to com-
bine the name of the basic hydrocarbon (such as androstane) with the
ending-one whichdesignates thepresence of aketone group. The carbon
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atom involved in the ketone group is indicated by the appropriate
number. Thus, the name androstan-17-one means that the compound
has the androstane skeleton and a ketone group at C-17; androstane-3,
17-dione means that there are two ketone groups, one at C-3 and one at
C-17. The symbol A indicates the presence of a double bond and a
superscript shows the position of the double bond, thus A4 indicates the
presence of a double bond between C-4 and C-5. Further, the basic
hydrocarbon is then designated as being unsaturated by the ending-ene,
for example, A4 androsten-17-one. If there is any possibility of
ambiguity the positions of both ends of the double bond are given,
thus A89 or A'14. If more than one double bond is present, as for
instance a double bond between C-3 and C-4 and one between C-5
and C-6, the positions would bedesignated as A3'5 and such a compound
would be called a diene. An example would be A35 androstandien-
17-one.
The presence of a hydroxyl group is indicated by the ending -ol;
for example, androstan-3-ol designates the androstane skeleton with
a hydroxyl group substituted at C-3. The presence of a ketone and an
alcohol group is shown in the name androstan-3-ol-17-one. When a
hydroxyl group is substituted for a hydrogen atom two sterioisomers
become possible. As an aid in terminology the terms alpha (a) and
beta (,8) * were suggested by Fieser to denote the steric relation be-
tween the rest of the molecule and the hydroxyl group at C-3. This
terminology has been extended to include other positions (e.g., C-17,
C-1i, C-20, etc.). By convention the alpha position is designated by
a dotted valency bond, indicating that the attached group is below the
plane of the ring, and the beta position by a solid valency bond in-
dicating that the attached group is above the plane of the ring. With
these facts in mind it is clear that the compound etiocholan-3 (a)-ol-
17-one, a so-called 17-ketosteroid, would have the following struc-
tural formula:
Precise designations of molecular structure are
0 necessary since isomeric variations within the
molecule not only result in altered physical and
chemical properties but may account for the
.140 | presence or absence of biological activity.
N10 , | The nature of the adrenal and gonadal steroids
FIG. 2 Acomprehensive review of the various roles
played by the steroid hormones in physiologic
* Although not as convenient, the terms trans and ciS are sometimes used to denote
thealpha and beta positions, respectively.
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processes cannot be attempted. For detailed data the reader is referred
to several excellent review articles.26 108, 109, 148, 214 However, a brief
survey of some of this available information must be made before one
attempts to interpret the significance of the steroid excretion products.
One must consider the possible nature of the steroids as found in the
organism before excretion, their major biological actions and trans-
formations, and certain factors which are known to influence their
secretion. Since the adrenal cortex and male gonad appear to provide
the main source of steroid hormones which give rise to the neutral
urinary steroids, the major portion of the discussion must concern itself
with the hormones of these glands. The r6le played by the secretions
of other endocrine glands will be included only in so far as these
appear to affect the adrenal and the testicle.
Thesteroidsoftheadrenalcortex
When early studies",9 115 143 213 on adrenal extracts and steroid
hormones were being carried out it became difficult to ascribe all the
observed effects to one adrenal cortical hormone. Since then a sur-
prisingly large number of crystalline steroids have been isolated from
theadrenal,differingqualitatively andquantitativelyfromoneanotherin
their biological actions. In Table 1 are listed the 28 steroids1"O
thus far isolated from the adrenal cortex. It will be noted that 11 of
these compounds have proved to be biologically active; the remainder
are either inactive or their biological activity has not yet been reported.
Except for the androgenic compounds and estrone, the physiologically
active adrenal steroids contain an a,,8 unsaturated 3-ketone and the two
carbon side chain at C-17 and are therefore A4 pregnenes. The majority
Table 1
ADRENAL STEROIDS GROUPED ACCORDING TO THEIR MAJOR BIOLOGICAL EFFECTS
A. Carbohydrate metabolism (C-21 steroids, 5 oxygen)
I. A4 Pregnene-l1(,8),17(,8),21-triol-3,20-dione
(17-hydroxycorticosterone or Kendall's cpd. F)
II. A4 Pregnene-17(,8),21-diol-3,11,20-trione
(17-hydroxy 11-dehydrocorticosterone or Kendall's cpd. E)
Remarks: Cpds. I and II increase the rate of glyconeogenesis
from proteins and other precursors when this is necessary
and retard the rate of glucose disposal;111 148 the site of
action and the extent to which fat is involved still is
somewhat obscure;109 they may cause a temporay in-
crease in sodium excretion226 and appear to be less effec-
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(Table 1 Cont.)
tive than Cpd.V to maintain the life of the adrenal-
ectomized animal.1'5
B. Carbohydrate, and salt and water metabolism (C-21 steroids, 4 oxygen)
III. A4 Pregnene-11,21-diol-3,20-dione
(corticosterone or Kendall's cpd. B)
IV. A4 Pregnen-21-ol-3,11,20-trione
(11-dehydrocorticosterone orKendall's cpd. A)
Remarks: Cpds. III and IV have similar but less intense
actions on carbohydrate metabolism'10 210,241 and the
effects vary in different testanimals;210 they cause moderate
retention of sodium, chloride, and water and lengthen the
lives of adrenalectomized animals.109' 151
C Saltand watermetabolism (C.21 steroids, 3 and 2 oxygen)
V. A4 Pregnen-21-ol-3,20-dione
(11-desoxycorticosterone)
VI. A4 Pregnene-3,20-dione
(progesterone)
Remarks: Cpd. V, isolated in very minute quantities from
the adrenal cortex,'89 has powerful effects on sodium,
chloride, and water retention and is the most efficient
steroid known to prolong the lives of adrenalectomized
animalswhen these arenotexposed tocertain stresses."15'151
Cpd. VI has similar, but much weaker actions; its most
prominent feature is its well-known progestational effect.
D. Androgenic (C-19steroids)
VII. Androstane-3(/3),11(,8)-diol-17-one
VIII. A4 Androstene-3,11,17-trione
(adrenosterone)
IX. A4 Androstene-3,17-dione
X. A4 Pregnen-17 (? )-ol-3,20-dione (C-21 steroid)
(17-hydroxyprogesterone)
Remarks: It is uncertain whether Cpds. VII, VIII, and IX
naturally occur in the fresh gland. Although evidence is
lacking, these compounds may originate by oxidation of
C-21 steroids during the process of isolation. Cpd. X has
about the same androgenic activity as androsterone.
E. Estrogenic (C-18 steroid)
XI. Estrone
F. Inactive compounds and compounds whose action has not been determined.
XII. Allo Pregnane-3(/3),11(,8),17 (/8),20(?),21-pentol (inactive)
XIII. Allo Pregnane-3(/3),11(,/),17(/3),21-tetrol-20-one
XIV. Allo Pregnane-3(a),11 (?),17(,8),21-tetrol-20-one
XV. Allo Pregnane-3(,8),17(,/),21-triol-11,20-dione (inactive)
XVI. A4 Pregnene-11 (/3),17(/3),20(?),21-tetrol-3-one (inactive)
XVII. A4 Pregnene-17(/3),20(?),21-triol-3,11-dione
XVIII. Allo Pregnane-3 (/3),17(/3),20(/8),21-tetrol (inactive)
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(Table 1 Cont.)
XIX. Allo Pregnane-3(,8),17(,8),21-triol-20-one
XX. A4 Pregnene-17(/),21-diol-3,20-dione (inactive) (?)
XXI. Allo Pregnane-3(/3),11 (?),21-triol-20-one
XXII. Allo Pregnane-3(/3),21-diol-11,20-dione
XXIII. A4 Pregnene-20(? ),21-diol-3,11-dione
XXIV. a,,8 unsaturated ketone: constitution unknown (inactive)
XXV. Allo Pregnane-3(/3),17(/8),20(,8)-triol
XXVI. Allo Pregnane-3(,8),17(/3),20(a)-triol
XXVII. Allo Pregnane-3(/3),17 (8)-diol-20-one
XXVIII. Allo Pregnan-3(/3)-ol-20-one (inactive)
G. Amorphous Fraction: nature unknown.
of the inactive compounds are allo-pregnanes. Structurally, these active
compounds differ from one another only in the number and position of
attached hydroxyl or ketone groups and perhaps can be looked upon
as being in different stages of oxidation and reduction. The structural
relationships of certain of the adrenal, testicular, and urinary steroids
become clearer by examination of Fig. 3.
Except for three androgenic steroids (19 carbon atoms) and
estrone (18 carbon atoms) thephysiologically active steroids contain 21
carbon atoms (pregnene derivatives). Whether all these different sub-
stances are derived by differential degradation of one parent substance
and many of the isolated members being intermediate compounds or
whether the different hormones are built up separately and directly
from smaller fragments, remains to be determined. It has been sug-
gested that the androgenic adrenal steroids are not "true" adrenal
hormones butthattheymaybe artifacts derived bydegradation of certain
of the 21-carbon compounds during the isolation precedures. Evidence
for this assumption is lacking. As will be discussed later, certain clinical
and laboratory observations in man would indicate that the adrenal
indeed does elaborate androgenic substances and it would seem that
the quantities elaborated are in no direct way related, at least quantita-
tively, to those 21-carbon steroids concerned with protein, salt, and
water metabolism. However, the exact chemical and biological nature
of the "androgens" of adrenal origin is unknown.
The actual quantities of hormone elaborated and discharged into
the circulation by the normal adrenal is not known with certainty, since
the amounts of cortical hormone require merely for the maintenance
of life of adrenalectomized animals may be far different from those
required by the normal animal in optimal condition. By cannulizing the
adrenal vein Vogt236 was able to show that the adrenals of a 10 kg.
dog secrete an amount of hormone equivalent to at least 230 ml. of
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a commercial cortical extract per day (1 ml. of extract equivalent to
75 gm. of gland). If this is the case, its importance both clinically and
experimentally cannot be overestimated.
It should be
I.ADRENAL STEROIDS E.URINARY STEROIDSnoted, further, that
Ot(aOII after removal of
all crystallizable
material from the
oJ>J \ beef orhogadrenal
CORTICOSTERONE C"OS3K bLtetgNl¢- cortex an amor-
C,& copt.icosIr olws phous fraction re- v,|ACTANES mains in the PREQONANEcS O1'KI (?) mother liquor which contains the
DESOXY.CORtTCOSTeRONE principal part of
eo 0the original total
activity."16, 132, 158,
247 This fraction is
3 to 5 times as ac-
~ tive as desoxycor- ticosterone acetate
and 300 to 500 ANDR0STERONE times as able as
3E TESTICULAR srEtoto compound E
04l r (Kendall) to
maintain the life GETIOCHOL.ANOL'ONE of an adrenalec-
a tomized dog. The
TESTOSTERONa chemical nature of
this undoubtedly
ItO important fraction
DINVDROISOANDROSTEVOrIE iS wholly un-
Structural formulae of certain adrenal and testicular hormones and known. Its activity
urinary steroids. does not seem to
be due to any of the known biologically active adrenal steroids.
As noted in the table, the various steroids are segregated into groups
according to their major biological actions. Although such divisions may
be partially artificial it is necessary in view of our ignorance regarding
the formation and intermediary metabolism of these substances. Also,
since no one steroid from the adrenal can be universally accepted as a
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general standard of adrenal activity one cannot, with accuracy, speak of
"cortical" activity and convey a precise meaning. It is necessary, there-
fore, to designate the biological action more specifically. Thus, the
adrenal steroids have been grouped, in spite of some overlapping, into
those which exert an effect mainly on salt and water exchange, those
that act on carbohydrate and protein metabolism, and those which are
androgenic, estrogenic, or inactive. Some of the pertinent features of
their various actions are summarized in the table. A thorough under-
standing of these functions is imperative before the manifestations of
certain hypo- and hyperfunctioning lesions of the adrenal cortex in
man can be interpreted.
It is possible, but of course unknown, that identical substances are
elaborated by the normal human adrenal cortex. It is also unknown
whether abnormal adrenal cortices (adrenal tumors or hyperplasias)
elaborate abnormal steroids or whether disproportionate amounts of
normal hormones are produced. Further, since different species occa-
sionally react very differently to the same hormonal substance, it cannot
be assumed that the biological effect of asteroid in man will be identical
with that produced in a test animal. A substance might promote growth
of the capon's comb and be considered a potent "androgen" and yet
cause growth of the mammary gland and be a poor "androgen" in
man at certain periods of his development.
Thesteroids ofthetesticle
In Table 2 are listed those steroids which have been isolated from
animal testes. Testosterone is generally considered to be the male sex
hormone because of its potent androgenic properties and because of
its ability to reverse the regressive changes in the secondary sexual
Table 2
STEROIDS ISOLATED FROM THE TESTIS
Compound Animal source
1. Testosterone (A4 androsten-3-one-17 (a)-ol) Bul45
Remarks: Testosterone is strongly androgenic;215 prevents Horse215
cytologic "castration" changes in pituitary,5 largely
prevents testicular atrophy in hypophysectomized
animals and prevents retrogression of secondary sexual
characters of the castrated animal;175 promotes nitrogen
retention, apparently independently of other endocrine
glands, when nutritive substances are available;120 129
particularly metabolized to 17-ketosteroids.13
2. a-Estradiol (Al"3'5:10-estratriene-3,17 (a)-diol) Horse1s
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3. Estrone (Al,3,5: 0-estratrien-3-ol-17-one) Horse13
Remarks: Compounds 2 and 3 are well known for their
estrogenic effects. The actions of the following com-
pounds are largely unsettled.
4. A5 pregnen-3 (,/)-ol-20-one Pig'95
5. Allopregnan-3(,3) -ol-20-one Pig'95
6. A1 :17 androsten-3 (a)-ol Pig'88
7. A1617 androsten-3 (/3)-ol Pig'88
8. Androstane-3,17-dione Pig'79
9. Testalolone (C21H3203) Pig98
(structure uncertain196)
10. Several other crystalline compounds not fully identified.'95
characters consequent upon castration. For example, testosterone pre-
vents or repairs the atrophy of the seminal vesicle and prostate in
castrate animals and produces a masculine distribution of hair, acne,
increased musculature, and growth of the accessory male genital organs
in man. Its role in the maintenance of spermatogenesis, however, is
not entirely clear.
In addition to its well-recognized masculinizing and occasionally
defeminizing effects, testosterone is known to bring about other
metabolic changes in the organism. Suffice it to state that in a variety
of clinical conditions (e.g., normal males and females, aged men and
immature boys, hypogonad males and females, patients with adrenal
or pituitary insufficiency) administration of testosterone results in
nitrogen retention and provides a gain in body weight.125 Associated
with these changes theregenerally is aslight retention ofother elements,
such as calcium, phosphate, sulfate, sodium, potassium, and chloride.
These observations have been taken to mean that new body tissue is
being formed under the influence of the hormone.2'119 220 It would
appear that this effect is a rather direct one and not mediated through
or entirely dependent upon the secretions of the other endocrine
glands.129 From available evidence it is clear that there are other
important factors which modify the effect of testosterone (or its esters)
on protein anabolism. The observation that eunuchoid patients and
castrate animals retain more nitrogen than do normal men or
animals19' 127, 130 would indicate thatthepresence ofnormal endogenous
androgen may diminish the response to the hormone. Also, eunuchoid
patients retain as much nitrogen when 25 mg. of testosterone pro-
pionate per day are administered as when larger amounts are given.'25
Further, an intercurrent illness may diminish the nitrogen retention or
even cause a negative nitrogen balance in spite of testosterone adminis-
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tration.23 Kenyon18 showed adecrease in theeffectiveness of testosterone
propionate on the excretion of nitrogen when the nitrogen intake was
decreased from 13.5 gm. per day to an inadequate intake of 1.7 gm.
and when the caloric level was reduced from 2816 calories to 1589
per day. Obviously other factors, nutritional and adaptive in nature,
which may or may not be under endocrine control, are instrumental in
modifying the response to administered testosterone. From these ob-
servations one certainly cannot infer that all anabolic processes are
mediated byway of androgenic hormones any more than one can deduce
that adjustments to dietary change are entirely under control of the
endocrine system as we understand it. Also, from Kochakian's extensive
data128it is clear that there is no necessary parallelism between "andro-
genic" activity and "anabolic".activity exhibited by different steroids.
Since the precise nature of the "androgens" elaborated by the normal or
pathological adrenal cortex is unknown, it has not been possible to
demonstrate directly that these are anabolic in man. However, since
certain individuals suffering from adrenal cortical neoplasm or hyper-
plasia exhibit virilism and accelerated growth, it has been suggested2
that the adrenal, under these circumstances at least, elaborates hormones
which favor the deposition of new tissue.
Although estrone, estradiol, and several other steroids have been
isolated fromtestes, theirphysiological significance in the male organism
is entirely obscure. It is well known that the human male excretes
estrogen in the urine in appreciable amounts and the observation that
castration leads to a fall in estrogen excretion202 would lend support
to the view that at least part of the endogenous estrogen is derived
from the male gonad. There is some indirect evidence that this estrogen
is elaborated by the Sertoli cells of the testis"' or possibly by the
seminiferous tubular elements.65 126 There is rather conclusive evidence
that testosterone is elaborated by the interstitial (Leydig) cells.'64 It
appears that the tubular and interstitial cell elements are under separate
gonadotrophic control. In normal, immature, and hypophysectomized
male rats the follicle-stimulating hormone stimulates the tubules to
spermatogenic activity without affecting androgen production of the
interstitial cells.64 Androgen secretion appears to be under control of
the luteinizing hormone.80
Androgenicandestrogenicactionsofsteroidhormones
An"androgen" canbe defined as asubstancewhich, liketestosterone,
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will stimulate the development of the accessory male organs or char-
acters. The term "estrogen" usually means a compound which, like
estrone, will induce cornification of the vaginal mucosa of the adult
mouse and which, broadly speaking, assists in the development of
organs appropriate to the female. Though the terms "androgen" and
"testrogen" sometimes may be useful to convey a general meaning, it
must be recognized that the actions of these so-called "male" and
"female" sex hormones are not sharply limited to one anatomical loca-
tion or to one type of response. A compound would be considered to
be an "androgen" if it stimulates comb growth in the capon, while
the same compound would be called an "estrogen" if it produced
vaginal cornification or stimulation of the mammary gland. Even
testosterone has been shown directly to elicit vaginal cornification47' 172
as well as to produce lobule-alveolar growth of the mammary gland67.
133, 134 when sufficiently large amounts were used. Many substances
(e.g., A' androstene-3,17-diol, ethinyltestosterone, dehydroisoandros-
terone) appear to be almost as estrogenic as androgenic in their
activity. In male chicks androsterone and dehydroisoandrosterone
have strongly feminizing effects;246 their biological action in the
human is uncertain. In view of our clumsy terminology it becomes im-
perative to specify precisely whenever possible, the various biological
actions of each individual substance rather than endeavor to place a
substance entirely into one group or another. The nature and intensity
of the biological response to a "sex hormone" appear to vary in different
species and in different organs and at different ages of a species. Just
as there is overlapping of the actions of the biologically active adrenal
steroids, there is overlapping of the potentialities of the so-called sex
hormones. The duality of action in some instances may be due to the
biological conversion in the body of one substance into another;106
in other instances the duality of effect may reside in an inherent char-
acteristic of the compound.
Factors controllingadrenal corticalandgonadalsecretions
The complex factors involved in controlling the formation and
secretion of the steroid hormones are onlypartially understood. Without
knowledge or recognition of these factors it is exceedingly difficult,
particularly when dealing with clinical conditions in man, to interpret
precisely the significance of changes in the excretion of steroids which
arise from precursor hormones.
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That the anterior pituitary is responsible in some manner for a
major portion of the control of the adrenal has long been known. The
mechanisms whereby itexerts its effect have been recently only partially
and indirectly elucidated. In animals hypophysectomy leads to atrophy
and decrease in weight of the adrenal corticies;'08 the atrophy being
moremarkedin theinnerthan in theouter zones. Also, anteriorpituitary
insufficiency in man is accompanied by a decrease in adrenal size.
Hypophyseal implants or the administration of the adrenocorticotrophic
hormone of the pituitary prevents the degenerative changes in the
adrenal corticies which otherwise occur in hypophysectomized animals.
Withincreaseddosesofadrenocorticotrophic hormonegrosshypertrophy
and hyperplasia of the adrenal cortex result. From this evidence it is
apparent that the pituitary influences at least the size and structure of
the adrenal cortex. The role played by the pituitary in affecting adrenal
composition and function has been revealed by more recent data. These
later studies have consisted mainly in the measurement of certain
phenomena associated with the administration ofpurified adrenocortico-
trophic hormone, or with its activation by other means, in normal and in
hypophysectomized animals.
The high concentrations of cholesterol and ascorbic acid iii the
adrenal cortex have long intrigued the investigator. It has not been
directly demonstrated that the cholesterol in the adrenal is transformed
to adrenal hormones, nor has the function of the ascorbic acid been
clarified. However, when adrenocorticotrophic hormone is administered
to certain experimental animals there is a rapid, temporary fall in
ascorbic acid content and a slower, temporary fall in cholesterol con-
tent of the adrenal without alteration of their concentrations in other
tissues."' 20 These changes are associated with a rise of liver glycogen
and a lymphopenia, both manifestations being considered to be an in-
dication of increased output of certain of the cortical hormones.' 199
Similar rapid changes in adrenal cortical concentrations of ascorbic
acid and cholesterol (presumably associated with increased secretion of
cortical hormones) are observed following the subjection of the animal
to avariety ofstimuli,90 198 199 e.g., exposure tocold, burns, hemorrhage,
sciatic nerve stimulation, and injections of histamine or epinephrine.
That this response is mediated through the pituitary is suggested by
thefactthattheobserved changesdo notoccurin thehypophysectomized
animal; in other words, before a stimulus can affect adrenal cortical
secretion there must be a preliminary activation of the anterior pituitary
to alter its pattern of secretion. The fundamental mechanism involved
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in firing the pituitary into activity under such a variety of conditions
still remains to be elucidated. A lowering of the level of circulating
cortical hormone198 or activation of the sympathetic nervous system
with release of epinephrine,'42 has been suggested as the possible
common factor possessed by such stimuli. That similar environmental
andpossibly nervous influences might affectthegonadotrophic secretions
of the pituitary has been indicated, experimentally, in the rabbit, cat,
and rat.10 65 66 Certain clinical observations would lead one to believe
that analogous mechanisms occur in man.75 However, it is apparent that
the manner in which changes in pituitary secretion are brought about
will not be understood until information is available regarding the
precise manner in which the adrenal and gonadal hormones are
utilized or disposed of in the organism. In any event, at least one effect
ofenvironmental change is an alteredpituitary secretion with a resultant
change in the secretion of the adrenal and possibly other hormones.
This fact must be recognized when attempting to interpret the result
of hormonal assays in man.
The environmental factors noted above which are known to modify
pituitary control of the peripheral endocrine glands do not provide a
complete picture of these controlling influences. It appears that the
pituitaryis very sensitive to various nutritive deficiencies. More is known
about the effect of nutrition on the gonadotrophic hormone than on the
adrenotrophic hormone. In 1930 Mason and Wolfe160 showed that
the gonadotrophic activity of the pituitaries of female rats was lowered
by inanition. Later, Moore and Samuels167 showed that diets low in
thiamin or calories damaged the secondary sex glands and that gonado-
trophichormone was able to repair this damage. Other studies indicate a
similar response by the pituitary to a low protein intake. Again
gonadotrophic hormone prevented the deleterious effects.82 That the
adrenotrophic hormone is also affected by inanition is suggested by the
extensive studies of Mulinos and Pomerantz."', 17 It is important to
realize that the noted dietary deficiencies did not impair the responsive-
ness of tissues to stimulating steroid hormones, rather the deficiencies
appeared to cause a quantitative reduction in endogenous formation
of hormone by the pituitary. An evaluation of the significance of the
excretion of hormones in man must, therefore, be considered also in
the light of past or present nutritional deficiencies.
Another factor which may govern the activity of any one endocrine
gland is the functional status of the others. The literature on this
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subject is enormous and reference to this aspect of the problem is
included only in an endeavor to complete the picture. Sevringhaus206
gives a complete survey of data up to 1939 regarding the various
cellular changes in the anterior pituitary that occur associated with
castration, pregnancy, hyperthyroidism, hypothyroidism, adrenal cortical
insufficiency orhyperfunction, and with the administration of androgens
and estrogens. Swann2"2 has discussed the pituitary-adrenocortical, and
Parkes"80 the adrenal-gonadal relationships. Moore65' 166 and Koch"26
have reviewed the various biological interrelationships concerned with
testicular and androgen function, and Allen, Hisaw, and Gardner7
have discussed the ovary and its hormones in this regard. More recent
reviews should also be referred to, particularly those of Fevold64 and
Levin'36 on the gonadotrophins, Long141 on the metabolic hormones of
the anteriorpituitary,Marx andEvans150 on thegrowth hormone,Ingle"09
on the adrenal cortical hormones, and Lukens"45 on the action of insulin.
The close functional relationship between the various members of the
endocrine system is clear. At times, however, it is exceedingly difficult
to determine whether an observed effect of a hormone is a direct result
of its action orwhether the effect is brought about in an indirectmanner.
by altering the secretion of other glands. Further, when changes in an
endocrine gland occur (e.g., degenerative, hyperplastic, or other) after
the administration of a hormone, or even another substance, it is im-
portant to know whether the effect is a direct one on the gland itself,
an indirect onemediated through another gland, or whether the changes
are the result of a secondary response to an extra-endocrine mechanism.
Factorswhich may conditiontheresponse to hormones
When one is confronted with a patient with an endocrinological
disorder one naturally would like to know which hormones are being
produced in abnormal quantities. One also asks to what extent the
clinical picture can be explained on such a quantitative basis. When one
endeavors to do so, it soon becomes obvious that in clinical as well as
in experimental endocrinology there are certain factors which will
modify and condition the response to a hormone or its transformation
product. Reference to some of these determinants must be made.
Certain of the problems met with in this phase of medicine involve
such complex and poorly understood mechanisms as sex determination,
intersexuality, sex differentiation, and maturation phenomena, all of
which must be evaluated in any individual case. The factors of sex
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determination (the sex of the gametes) appear to be mainly, if not
entirely, chromosomal (genetic) in nature and are subject to the
usual lawsofMendelian inheritance. The cells of the developing embryo
are at least qualitatively different in the two sexes and this original
difference subsequently must give rise to the ultimate difference between
the sexes. Sex differentiation (sex in bodily structure) appears to be
adaptive in nature and is a complicated process. It appears that each sex
combines potentialities of both the male and the female type, and the
rudiments of the secondary sex characters, male and female in type, are
laid down during the development of every individual. Whether the
major expression is in one direction, or another may depend on a
hormonal level, on an inherited chromosomal level, or on both. It is
generally believed that in vertebrates and mammals, the mechanism
of sex differentiation is largely taken over by extracellular agents, i.e.,
the male and female sex hormones, since the first indication of sexual
differentiation is in the gonads. This concept grants that the nature of
theendocrinecellsproducing the hormones isfirstdetermined by inherit-
ance.Thus,thedevelopmentofthedifferences between thesexeswould be
based on differences in hormone elaboration and the soma indeed could
beconsideredsexually neutral or indifferent. Masculinization and femini-
zation of sex characters could occur with equal ease depending only on
hormonal activity. In other words the primordium of any pair of sex
characters would be responsive to both male and female hormones in
opposite ways."48 In fish and amphibia the neutral or indifferent phase
of the soma appears to persist until puberty. In mammals, however,
this indifferent period is very short and sex differentiation is partially
achieved by the time of birth. At this time the whole genital tract is
differentiated. Moore166 has raised serious objections to the concept
that sex hormones of the developing gonads play an important role in
the differentiation of the embryonic, reproductive duct system, although
he does not deny their probable importance during later development.
However, after a critical review of available data he is led to conclude
that "the most acceptable evidence for the control of sex differentiation
in vertebrates rests upon the conception of the operation of genetic
sex differentiating factors unconnected with sex hormone actions." In
any event, in man from birth until puberty there is a very gradual,
further differentiation, especially as regards body growth, mammary de-
velopment, and behavior. At puberty voice changes, hair growth, and
gonadal activity complete the differentiation. It therefore becomes clear
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that when a major developmental anomaly of the genital tract is
observed in man the defect and its cause must have originated before
birth. Also, when abnormal hormonal influences are developed experi-
mentally or spontaneously in a patient, after birth but before puberty,
those characters of sex that develop later (e.g., hair, voice, growth,
gonadal function) will be more profoundly affected than those which
develop earlier. In fact, by the time of birth certain of the primordia of
the heterologous sex have so nearly disappeared that their further
development may be impossible, or at least not apparent. Thus the
maturity of the individual, as well as the genetic sex, is an extremely
important factor in conditioning the response to hormonal influences.
The importance of this concept is clear when one endeavors to account
for the clinical pictures produced by 'tmasculinizing" tumors of the
adrenal cortex in boys, girls, men, and women. Thus, an abnormal
masculinizing influence would be apparent in children or women, since
at least certain of the male rudiments (hair, voice, penis, or clitoris)
are able to react positively to an androgenic effect. However, a
similar influence would not be apparent in previously normal males
whose masculine characters are already fully developed. An increase in
estrogenic influences from any cause would not be readily recognizable
in the soma of the previously normal woman, while the effects, if
sufficiently great, might be noted in men or children. Even with
entirely similar hormonal influences one could not expect to see identical
clinical phenomena in individuals of different age and sex.
The importance of sex hormones in governing the development of
sex character and function cannot be denied, in fact an entire book has
been mainlydevoted to this problem.6 From the standpoint of hormonal
control, an organism becomes male in type under the influence of
androgenic hormones and female under influence of estrogenic
hormones; each primordium would be responsive to both hormones in
opposite ways and the degree and nature of the response could be
closely correlated with the quantities and nature of hormone elaborated.
If this were the whole picture of sexual differentiation in all its subtle
aspects, experimental and clinical problems would be relatively simple.
Unfortunately, such a "hormone balance" theory, though attractive,
leaves much to be desired.166 There is, however, a broader and probably
more truly correct explanation whereby hormones influence the differ-
entiation of sex characters in mammals.
From avariety ofclinical andlaboratory evidence one mustconclude
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that certain of the sex primordia are mainly responsive to androgenic
influences and others mainly to estrogenic influences. Hence, the male
or femitle form of any pair of sex characters would be a "conditioned"
character and the contrasting character would be "unconditioned" or
relatively neutral. For example, the penis of the genetic male responds
positively and easily to androgenic hormone while the clitoris of the
female, being an "unconditioned" character, merely responds as a
generally neutral or indifferent character. Normally, the unconditioned
sex character is a rudimentary structure and the organs of each sex
reactto themale or female hormone in their own special way. Thus, one
would conclude that inherited, nuclear characteristics of the soma and
of the secondary sex characters would influence responses to hormones.
In other words, in order to interpret a response one must consider the
biological soil on which the hormones act. Further elaboration on this
point is necessary since it is likely that the "hormone balance" theory of
sexual differentiation may be an oversimplification. The following bits
ofevidence mightbe cited. If the excretion of androgenic and estrogenic
hormones in urine can be considered as a rough quantitative measure of
endogenous elaboration of these hormones, the fact that no significant
difference in their excretion can be demonstrated in young boys and
girls, in spiteofpartial sexdifferentiation, would indicate a fundamental,
genetic difference in their response to elaborated hormones. Further,
in entirely normal adult men and women, there is great overlapping
in estrogen, androgen, and 17-ketosteroid output by individual members
of both groups. Admittedly, adult males, on an average, excrete more
androgen and less estrogen than do the majority of females, but
considered individually, the differences are not usually distinctive of
either sex. Experimentally, as pointed out by Moore,'65 "the Mullerian
ducts of males and females at the same period of development exhibit
entirely different capacities to respond to one and the same substance."
These structures must, therefore, have been previously conditioned in
some, probably genetic, manner.
Not only will the genetic sex of an organism influence a response,
but the same sex in different species or in different strains of the same
species may exhibit different responses to the same hormonal influence.
In this regard the fact that the male American Indian lacks a beard de-
pends upon a racial characteristic and not on a lack of androgenic
hormone. Further, many cases of hirsutism in post-pubertal women
appear to be on a hereditary or familial basis, since no deviation from
normal is apparent either in hormone excretion or in gonadal or other
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endocrine function. In these cases the offending end-organ would seem
to be unusually sensitive to masculinizing influences. Danforth has
admirably discussed the variations in response to natural and synthetic
hormones exhibited by different breeds and species of fowl under a
variety of circumstances." From the above remarks, it is evident that
an inherited framework on which the hormones act determines the
nature of the reaction. However, the extent to which a hormonal in-
fluence or an inherited trait may each contribute to the development
oftheultimateresponse is notunderstood formost reactions. Ofnecessity
both determinants are functioning simultaneously and the line between
the action of one and the action of the other is not sharp. Also, it is not
necessary to consider an inherited characteristic of a tissue as an
immutable state. It is highly probable that when the various cellular
functions are betterunderstood certain "inherited" traits or so-called "in-
born errors of metabolism" will prove to be alterable.
Finally, one is confronted with the difficult problem of interpreting
the effect of hormones in terms of the chemistry of cells. Precisely how
do hormones bring about their effects? A ready answer is not available.
As has been pointed out,"4' hormones have not been shown to initiate
or cause reactions new to a tissue; rather, they appear to affect the rates
ofcertain of those chemical processes already characteristic of that tissue.
A good deal is known about the end results of hormone deficiencies and
of the overall effects of hormone administration, but little is known
of the chemical reactions involved in bringing about the final result.
Some of the major actions of the steroid hormones of the adrenal cortex
and gonads have been pointed out. Because of the nature of these
effects it would seem obvious that all nutritive and other elements
essential totheparticular reaction need bepresent andavailable, whether
new tissue is beingformed or the constitution of tissue is being otherwise
altered. The fact that the response to stilbesterol is impaired in a chick
deficient in folic acid95 might be cited as a single example of a
nutritional deficiency leading to a loss of responsiveness on the part of
a tissue. However, very little is known regarding those cellular systems
which involve the interplay of steroid and protein hormones, vitamins,
enzymes, and foodstuffs. Preliminary work along these lines is referred
to in recent literature.96
Biologicaltransformationsofsteroidhormones
The biological transformations that steroid hormones undergo have
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been studied in four general ways. First, crystalline steroids have been
incubated with certain tissues (e.g., liver slices, bacteria, etc.) and the
crystalline transformation products isolated. Second, the abilityofcertain
tissues to alterthebiological activityofasubstance or anextract has been
investigated. Third, a steroid may be labeled with an isotope, admin-
istered to man or animal, and an excretion product isolated and tested
for isotopic activity. Finally, crystalline steroids have been given to
man and animals and the nature of the excretory products in urine de-
termined. Although the first three methods are in the preliminary stages
ofdevelopment, certain data deserve mention.
Owing to scarcity of crystalline material it has been impossible to
apply precise isolation procedures to an investigation of the transforma-
tions of the physiologically active adrenal steroids, e.g., corticosterone.
However, using methods of biological assay Vogt236 has shown that the
adrenal veins of dogs contain large quantities of physiologically active
material which rapidly disappear during circulation. Since the active
hormones are relatively stable in blood and since their excretion by
the kidney is small,185 these substances must have been rapidly in-
activated or utilized by the tissues. Further, Vogt236 concluded from in-
direct evidence that the liver did not play a predominant r6le in this in-
activation. Precise knowledge of the fate of the adrenal steroids is
clearly lacking.
Ithasbeen shownby implantation experiments in rats that estrogens
and testosterone are inactivated by the liver.'7 However, when rats are
given adietdeficient in vitamin B complex, testosterone but not estrogen
is inactivated."5 16 More specific studies would indicate that thiamin,
riboflavin, and methionine are necessary for the inactivation of
estrogen.83' 204 How specific these particular substances might be for
this reaction is unsettled, since Drill and Pfeiffer57 conclude that
"deficiency of the whole vitamin B complex affects the inactivation of
estrogen only through the concomitant inanition produced." Burrill and
Green25 have presented evidence that "androgen" derived from the
adrenal is not inactivated by passage through the liver, while "gonadal
androgen" appears to be inactivated. The above studies on the role
played by the liver in these transformations have been carried out in the
rat. Since steroid hormones appear to be handled differently by different
species of animals, it would seem premature to conclude that entirely
similar mechanisms of transformation are present in man.
Using a colorimetric method for determining the presence or
absence of testosterone, Samuels et al.'97 showed that livers of rats, mice,
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rabbits, and man destroy testosterone, while rabbit uterus and rat
prostate do not. Theprocess of inactivation appeared to be an enzymatic,
oxidative reaction and did not seem to involve conjugation with other
substances. Although the transformation or degradation products were
not chemically identified, it was concluded that, at least in the animals
tested, the final products were not 17-ketosteroids, A4 androstene-3,
17-dione or the unnatural compound, cis-testosterone. However, by
isolation and characterization of the transformation products Clark and
Kochakian39 showed thattestosterone ismetabolized byrabbit liver slices
in part to A4 androstene-3,17-dione, cis-testosterone, and other partially
identified steroids. The factthatnone ofthe urinary-steroids (e.g., andro-
sterone or etiocholan-3(a)-ol-17-one) were found might indicate that
tissues other than liver may be involved in the formation of urinary
steroids from testosterone.
The isotopic labeling of steroid and other molecules has provided
interesting and valuable information regarding the origin of steroid
substances. For example, Bloch and Rittenberg2' demonstrated that
cholesterol may be formed from small carbon fragments, i.e., from
acetate; further, that cholesterol may be degraded in the organism to
bile acids.20 Later Bloch19 showed that pregnane-3 (a),20(a)-diol, a
metabolite ofprogesterone, was derived, at least in part, from exogenous
cholesterol during pregnancy. This latter study provided the first direct
demonstration that a hormonal product could be derived from
cholesterol.
Certain crystalline steroids, more readily available than the active
adrenal steroids, have been administered to man and the nature of the
excretory products in urine determined. These substances have been
given to individuals suffering from anterior pituitary, adrenal cortical,
or testicular deficiency inasmuch as the endogenous elaboration of
steroids in such cases should be small. This method is particularly
valuable since it is applicable directly to man. However, because of
technical difficulties inherent in present isolation methods its value
has been mainly qualitative. An accurate evaluation of the quantitative
conversion of an injected compound to a transformation product must
wait further investigations. In Fig. 4 are summarized various trans-
formations known to have occurred in man. Although these trans-
formations occur to a certain limited extent, it must be admitted that
the major portion of the injected material does not appear in urine
as the usual, known urinary steroids. Apparently this major portion is
metabolized and disposed of in some other, unknown manner. From
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Known Conversions of lNeutral Steroids in Man
Adrenal Cortical Excretion Products Testicular Steroids
Steroids
A. Androgenic Substances A. 17-Ketosteroids
(C19 Steroids) (C19 Steroids)
A4 androsten-3-17 dione (54) Testosterone (33 51)
(Ci9 Steroid)
! rsandrosterone. I
intermediates (?M)- intermediates C?)
Precursor (?) etiocholen-3(a)ol-17-one
4?
dehydroisoandrosterone (155515X/
isoandrosterone
intermediates (?)
\' ~dehydroisoandrosterone
B. Non-ketonic alcohols
A5 androsten-3(03) ,17-diol
B. Progesterone (88)
(C21 Steroid) - pregnane 3(a),20-diol
(C21 Steroid)
intermediates (?)
C. Desoxycorticosterone (43)
(C21 Steroid)
D. "Corticosteroids"
(Compounds E, F, A and B - - Unknovn.
of Kendall)
FIG. 4
the data it is clear that the testicular hormone, testosterone (free or the
propionate), gives rise to certain of the urinary 17-ketosteroids; mainly
the androgen, androsterone, and the biologically inactive compound
etiocholan-3(a)-ol-17-one. However, 17-methyltestosterone, asynthetic
androgen, is notdegraded to 17-keto compounds apparently because the
methyl group interferes with the oxidation of the hydroxyl group at
38,73i- carbon 17. From many observations, it is apparent that at least
two-thirds of the total 17-ketosteroids which appear in normal male
urine and probably all the 17-ketosteroids that appear in female urine
are derived from the adrenal cortex. It is clear also that androsterone
and etiocholan-3(a)-ol-17-one are the two 17-ketosteroids found inYALE JOURNAL OF BIOLOGY AND MEDICINE
greatest amounts in normal urine.33' 34,35,48 Both are found in ap-
proximately equal quantities and together account for at least 70 per
centofthe total.48 Both are derived from steroids elaborated by the male
gonad and the adrenal cortex. Undoubtedly testosterone is a precursor
in the male. Although the nature of the adrenal precursors remains
obscure, the various possibilities must be considered.
A re-examination of Table 1 wherein the steroids isolated from beef
adrenal are listed, reveals that compounds I-IV are 11-oxygenated
pregnene derivatives, compounds V and VI are 11-desoxy pregnenes,
compounds VIII and IX are androgenic androstenes, and compound X
is an androgenic, 17-hydroxyl-pregnene. Thus far there is no convincing
evidence that compounds I to VI, the steroids which affect electrolyte
and carbohydrate metabolism, provide a major immediate source of the
urinary 17-ketosteroids in man. The transformation of these pregnenes
to 17-ketosteroids would involve the oxidative removal of the 2-carbon
side chain at C-17. The in vitro, chemical removal of this side chain
occurs most easily in compounds with a hydroxyl group at C-17 (e.g.,
compounds I, II, and X). By removal of the 2-carbon alkyl group and
reduction at C-11, it is conceivable that adrenal steroids with an
oxygen function at C-11 could be metabolized and excreted as the
more common 17-ketosteroids. However, the ease whereby biological
reduction occurs at C-11 remains unknown. Small amounts of urinary
17-ketosteroids39' 152, 153, 163 have been isolated which are oxygenated or
unsaturated at carbon-11. These substances may have originated from
C21 adrenal steroids provided oxygenation of C19 compounds never
occurs at carbon-11. The urinary 17-ketosteroids (C19 compounds)
which normally are found in greatest amounts do not possess an 11-oxy
function. Certain clinical and laboratory observations are pertinent
in this regard. In many cases of Cushing's syndrome, not due to adrenal
neoplasm, there are evidences of adrenal cortical hyperfunction and
of excessive amounts of the "glycogenic corticosteroids" in urine216' 232
and yet, the total 17-ketosteroid excretion remains within normal limits.
Venning has shown that the excretion of "glycogenic corticosteroids"230
and of pregnane-3 (a),20(a)-dio1230 increases progressively during
pregnancy. No increase or change in 17-ketosteroid excretion was ob-
served. Also, in cases of pre-pubertal and post-pubertal virilism (not
associated with adrenal neoplasm) the 17-ketosteroid excretion may be
greatly increased (see below) while the "glycogenic corticosteroid"
excretion remains normal216' 232 and no abnormalities of carbohydrate
or salt metabolism are apparent. Mason154 administered 200 mg. of
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11-dehydrocorticosterone (compound A) to three patients with
Addison's disease and was unable to detect a rise in 17-ketosteroid ex-
cretion with the amounts used. Also patients exposed to chronic stresses
(burns, operations) excrete increased amounts of "corticosteroids"
while they excrete decreased amounts of 17-ketosteroids.68 234 In other
words, there appears to be no uniform parallelism or necessary linkage
between "corticosteroid" excretion (perhaps a measure of glycogenic
and other cortical activities) and 17-ketosteroid excretion (perhaps a
measure of androgenic activity). Either these different cortical activities
are regulated by different factors or the tissues of the organism do not
metabolize or otherwise dispose of the precursor compounds in similar
manner under all circumstances. The former concept does not exclude
the possibility that the "androgenic" and "corticosteroid" hormones
arisefrom thesameparentsubstance orsubstances. The fact thatpurified
adrenocorticotropic hormone caused a rise in both 17-ketosteroid and
"corticosteroid" excretion in a normal individual'59 and in a person
with anterior pituitary failure227 would favor the latter possibility.
The problem is a difficult one and will not be settled until the
mechanisms of utilization and transformation of steroid substances by
human tissues are better understood.
Since there is no substantial evidence as yet that the adrenal steroids
which influence salt water, carbohydrate, and protein metabolism are
the immediate precursors of the usual urinary 17-ketosteroids, it is
possible that these urinary substances are derived from the androgenic
(compounds VII-X, Table 1) adrenal steroids or closely related com-
pounds. In Figure 4 dehydroisoandrosterone (a C19, 3 -beta-hydroxy
steroid, unsaturated-as is cholesterol at carbon-5) was placed in such
a manner as to indicate that it originated in the adrenal cortex in spite
of the fact that it has not been isolated from beef or hog adrenal. How-
ever, there can be no reasonable doubt that this compound or more
surely its precursor is formed in the human adrenal cortex. Dehy-
droisoandrosterone may be excreted in enormous quantities in the urine
of patients suffering from adrenal cortical tumors;` normal males and
females excrete small but equal.amounts;`5 and eunuchs excrete greater
amounts than normal males.36 Further, dehydroisoandrosterone has not
been shown to be a metabolite of testosterone. Normally, dehydro-
isoandrosterone accounts for about 5 per cent of the total 17-ketosteroid
excretion. It is interesting to note that Mason and Kepler155 157 have
shown thatinjected dehydroisoandrosterone can give rise to considerable
quantities of androsterone and etiocholan-3(a)-ol-17-one. Part of the
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dehydroisoandrosterone is excreted unchanged. Since this androgen or
more certainly its precursor arises in the human adrenal and since this
gland is an important site of androgen elaboration, this observation may
provide aclue as to the sourceof the commonest urinary 17-ketosteroids,
namely, androsterone, etiocholan-3(a)-ol-17-one, and dehydro-
isoandrosterone. These investigations are important also because they
indicate that a 3-beta-hydroxy steroid with weakly androgenic and
estrogenic properties can give rise to two 3-alpha-hydroxy steroids, one
with stronger androgenic properties than the injected material and one
biologically inactive. Hence, it is apparent that the biological activity
of an excretory product may not invariably reflect the biological activity
of its precursor.
It is apparent in Fig. 4 that progesterone and to a lesser extent,
desoxycorticosterone are converted to pregnane-3 (a),20(a)-diol. This
excretory product appears to be the chief end-product of progesterone
metabolism and its excretion seems to reflect, in a general manner, the
extent of progestational activity. It would appear that, under these cir-
cumstances at least, the C21 pregnenes are more easily transformed to
C21 pregnanes than to C19 steroids; the removal of the side chain to
form a 17-ketosteroid did not readily occur.
These studies in man have provided valuable information which is
necessary to an understanding of the significance of the end products of
steroid metabolism. However, they do not indicate whether the trans-
formations are mainly related to utilization or to inactivation of
hormones. Unfortunately no studies in man are available that might
indicate themanner in which a disease might influence these transforma-
tions. For example, it is not known whether a low level of steroid ex-
cretion invariably indicates a depressed phase of adrenal or gonadal
function or whether the decreased value indicates an altered rate of
transformation in other tissues of normally elaborated steroids. Similar
questions might be raised regarding high levels of excretion. Hence,
certain reservations must be kept in mind before levels of excretion
can be accepted as absolute measures of the extent of endogenous steroid
formation.
Thenature, state, andsource ofthe variousgroupsofsteroid
substances excretedin urine
In Table 3 are outlined the nature and source of the different groups
of steroid substances found in human urine. Table 4 summarizes the
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principles of the methods used for their individual determination. Since
the neutral and phenolic steroids are excreted in conjugated' water-
soluble form, it is necessary tohydrolyze the urine before extraction with
organic solvents. However, pregnane-3 (a),20(a)-diol is more fre-
quentlydeterminedbydirectprecipitation and isolation of the conjugate.
As has been repeatedly emphasized by workers in this field77 there is
no general method of hydrolysis which will, under all conditions, cleave
all of the conjugates without any alteration of the steroid molecule.
The urinary steroids are conjugated with several substances; they appear
mainly as the sodium salts of glycuronic and sulfuric acids. The in-
dividual conjugates differ in their stability. For example, sodium
pregnanediol glycuronide is easily hydrolyzed without apparent altera-
tion or destruction of the steroid. However, hydrolysis of sodium andros-
terone sulfate and sodium dehydroisoandrosterone sulfate has led to
varying degrees of alteration and destruction of the steroids. Hydrolysis
of androsterone sulfate caused the regeneration of the natural 17-
ketosteroid androsterone, as well as the formation of A2 or A3
androsten-17-one, an unsaturated, non-alcoholic 17-ketosteroid.233 The
latter product represents an artifact derived by dehydration of the
Table 3
GENERAL GROUPS OF STEROID SUBSTANCES EXCRETED IN URINE
Group
1. The 17-ketosteroids (conjugated)
(composed ofsaturated and un-
saturated 17-keto-alcohols or
non-alcohols)
2. Pregnanediol (conjugated)
(pregnane-3 (a),20(a)-diol)
Probable origin
Gland Major chemical precursors
Testicle 1 [Testosterone
Adrenal cortex Dehydroisoandrosterone (?)
Ovary (doubtful)J A4 Androstene-3-17-dione
lOthers but unknown
Corpus luteum
Placenta
Adrenal cortex
3. "Corticosteroids" (unconjugated ?) Adrenal cortex
(Chemically unidentified. Known
for its biological activity)
4. A group of non-ketonic alcohols and Adrenal cortex
closely related steroids
][Progesterone
HDesoxycorticosterone
J Others (?)
11-oxy adrenal steroids
Others (?)
Unknown
5. Estrogens (conjugated) Ovary
Adrenal cortex
Placenta
Testicle
Estrogens
Others (?)
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hydroxyl compound during the hydrolytic procedure. Several other
similar artifacts are known. Although not true excretory products, their
presence is not without significance, since they are artificial derivatives
of natural substances whose nature is usually known. Nevertheless, it
is clearthatto interpret the significance of total or individual ketosteroid
excretion conditions of hydrolysis must be accurately controlled.
After preliminary hydrolysis and partial purification the neutral
"17-ketosteroid fraction" may be assayed biologically for its androgenic
activity, or colorimetrically. The m-dinitrobenzene method of Zimmer-
man250 or the antimony trichloride method of Pincus"86 may be applied
to crude extracts if proper precautions are made65 174 or these methods
may be applied to the more purified ketonic fraction.22" Since patients
with adrenal cortical tumors frequently excrete large amounts of
dehydroisoandrosterone (a 3-beta-hydroxy ketosteroid), separation of
the partially purified crude extract into alpha and beta fractions by
digitonin precipitation may be carried out.71' 219 Each fraction then may
be assayed by the Zimmerman reaction. Since the antimony trichloride
reagent reacts poorly with dehydroisoandrosterone andother unsaturated
17-ketosteroids, it may not be as generally useful as the Zimmerman
method, properly employed. Although colorimetric assays are easier to
perform, it cannot be assumed categorically that present general chem-
ical methods yield more precise information than do biological methods;
each may have its particular virtue depending on the nature of the
problem. Biological assays, whilereflecting the androgenic activity of the
Table 4
GENERAL OUTLINE FOR THE PREPARATION OF URINARY EXTRACTS FOR ASSAY OF
STEROID CONTENT
1. The 17-ketosteroids: Hydrolize the urine with inorganic acid; extract with
organic solvent; wash with alkali to remove phenolic substances
(estrogens). Dried residue taken up in ethanol and assayed:
(a) Biologically for androgenic activity and/or
(b) Colorimetrically by:
1) Zimmerman reaction: saturated and unsaturated 17-keto-
steroids react with m-dinitrobenzene in alkali to form a
red color.
2) Pincus reaction: saturated 17-ketosteroids react with
antimony trichloride to yield a blue color.
(c) References for details (38, 61, 71, 73, 104, 174, 186, 219, 221,
250).
2. Pregnanediol: Extract the conjugated pregnanediol from urine with butyl
alcohol and precipitate the conjugate with acetone. The precipitate is
46SIGNIFICANCE OF URINARY STEROIDS
purified and dried. The weight of the precipitate (sodium pregnanediol
glucuronide) converted by means of a factor into an equivalent weight
of free pregnanediol.
(a) References for details (11,229)
3. Corticosteroids: Extract unhydrolized acidified urine with ethylene dichloride,
chloroform or similar solvent; wash with alkali to remove acidic sub-
stances; this crude fraction may be separated into ketonic and non-ketonic
fractions with Girard's reagent T. The crude fraction or the ketonic
fraction assayed:
(a) Biologically, for ability to protect the adrenalectomized animal
against certain stresses ("cold" test, "work" test, "glycogen" test
during fasting, etc.).
(b) Colorimetrically, by reducing or other characteristics.
(c) References for details (58, 93, 110, 144, 223, 235).
4. Non-ketonic alcohols and related steroids: Identified only by isolation and
characterization of the crystalline compounds.
extract, do notdetect inactive compounds derived from active androgens.
For example, etiocholan-3 (a)-ol-17-one, a known metabolite of the
androgens testosterone and dehydroisoandrosterone, has no androgenic
activity and its presence would not be detected by biological assay.
However, it would be detected by colorimetric methods. In this respect
chemical assays are distinctly superior since the 17-keto group is
quite resistant to vigorous hydrolysis and survives metabolic changes in
the rest of the molecule. Although all the urinary steroids with andro-
genic activity thus far studied, appear to have a 17-keto group, it
cannot be assumed that urinary androgens may not exist without this
grouping. There may, be conditions where biological assay would be
more informative than an assay of total 17-ketosteroids; however,
neither general method can be expected to yield the precise information
afforded by the actual isolation of the individual steroids.
Although pregnane-3 (a),20(a)-diol belongs in the general group
of non-ketonic alcohols, it was listed in Tables 3 and 4 in a separate
category. This compound was first isolated149 from human pregnancy
urine in 1929 and its relationship to progesterone later established.
Butenandt was the first to suspect that pregnanediol arose from the
in vivo reduction of progesterone. It was found that pregnanediol
was not excreted as the free steroid but as a water-soluble, biologically
inactive, easily hydrolyzed glycuronide.178 In spite of some early con-
tradictory reports it is now apparent that up to 46 per cent of in-
jected progesterone can be recovered as pregnanediol.88 The level of
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its excretion appears to be related mainly to the extent of endogenous
progesterone elaboration.231 However, it is possible that pregnenes other
than progesterone may be converted to pregnanediol.43 Progesterone
has been isolated from the corpus luteum8'30 and small amounts have
been found in the adrenal cortex.189 The elaboration of progesterone by
the placenta has been suspected.114 Normal males, and females in the
early phases of the menstrual cycle, excrete very small amounts of
pregnanediol. Larger amounts are excreted by women in the luteal
phase of the menstrual cycle23' and very large amounts are encountered
in the latter half of pregnancy. Also, occasional cases of adrenal cortical
tumor and of adrenal hyperplasia excrete increased amounts of preg-
nanediol.'56 In these cases it is possible that adrenal cortical pregnenes
other than progesterone act as precursors of pregnanediol.
The general principles of the Venning229 method for the determina-
tionofpregnanediol astheglycuronide are given in Table 4. Itshould be
mentioned that since the water-soluble complex is easily hydrolyzed
precautions are necessary to prevent the hydrolysis of the conjugate.
Certain extracts of urine appear to have biological actions similar
to the 11-oxygenated adrenal steroids. This fraction, for want of a better
term, has been designated as the "'corticosteroid" fraction since it resem-
bles in its activity those adrenal compounds which affect carbohydrate
metabolism, resistance to stress, and life maintenance. Studies on this
fraction are still in the preliminary stages of development. The chemical
identity of the substances contained in these extracts has not been
determined; nor is it known with certainty that they are excreted as
free steroids. However, there can be little doubt that the active sub-
stances are steroids. It is likely that at least some of the compounds
present in this fraction possess an a,,8 unsaturated ketone in ring A, an
oxygenated carbon at position 11, and an a-ketol side chain at C-17.
So far as is known, these features appear necessary for glycogen de-
position. Thea,,3unsaturated ketonegroup andtheprimary or secondary
alpha-ketol group possess reducing characteristics. On the basis of this
feature a colorimetric method has been devised for the assay of this
fraction.93 223 Another chemical method involves theperiodate oxidation
of the C-17 side chain to yield formaldehyde.'44 Although it would seem
rather unique to develop chemical methods for the determination of
substances not yet identified, preliminary studies would indicate a fairly
good parallelism between the results obtained by "chemical" assay
and by biological assay.93 The colorimetric methods, however, uniformly
yield muchhighervalues than dobiological methods. Urine undoubtedly
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contains biologically inactive pregnenes.
As previously noted the level of the 17-ketosteroid excretion may
provide a measure of the androgenic cortical activities but does not
necessarily reflect cortical activities concerned with carbohydrate and
proteinmetabolism. Itwould seem that ameasure of the "corticosteroid"
fraction would be a better measure of these latter functions. Support for
the validity of this interpretation has been gained mainly by rather
indirect observations. Certain biochemical and histologic responses
indicativeofcorticalhyperactivityoccur inexperimental animals90 199, 205
when exposed to certain stimuli (see earlier discussion). The fact that
human subjects, exposed to similar stresses, excrete increased amounts
of "corticosteroids" is generally interpreted to mean an increase in
adrenal activity.205 234 Also, patients with Cushing's syndrome excrete
large amounts, and patients with Addison's disease small amounts of
these substances.218 232 More direct evidence became available when
it was shown that the administration of the adrenocorticotrophic
hormone of the anterior pituitary159' 227 led to an increase in the titer of
this fraction.
Except for pregnane-3 (a),20(a)-diol little is known of the qualita-
tiveandquantitativesignificanceoftheconjugated,non-ketonic,alcoholic
steroids (group 4, Tables 3 and 4). They probably arise, in the main,
from steroids elaborated in the adrenal, and represent excretion products
in various stages of reduction and dehydration. The majority of these
compounds have been isolated from the urine of patients suffereing from
adrenal hyperactivity. The compounds have been identified only by
direct isolation; as yet, no chemical method has been developed for
their assay. For a detailed discussion of this group of substances the
reader is referred to articles by Mason and Kepler."06 Hirschmann,102
and Pincus and Pearman.'87
Any significant reference to the phenolic estrogens is prohibitive
in this review. They are included in Tables 3 and 4 merely to complete
the picture of the steroid substances found in human urine. Suffice it
to state that the estrogens are excreted as conjugates and are weakly
acidic (phenolic) in character. They apparently arise from the ovary,
the adrenal cortex, the placenta, or testicle, and appear in urine as
estrone, estriol, or estradiol. The intermediary metabolism of the
estrogens is hardly better understood than is that of the androgens.
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Table 5
NEUTRAL 17-KETOSTEROIDS AND CLOSELY RELATED NON-KETONIC ANDROSTANES AND
ETIOCHOLANES WHICH HAVE BEEN ISOLATED FROM NORMAL AND PATHOLOGICAL HUMAN URINES (C19 STEROIDS)
A. Ketonic:Alcoholic
1. 3-Alpha (a), 17-ketosteroids
(digitonin non-precipitable)
(a) androsterone
(androstan-3(a)-ol-17-one)
(b) etiocholan-3(a)-ol-17-one
(c) A' androsten-3(a)-ol-17-one
(d) androstane-3(a), 11-diol-17-one
(e) etiocholan-3(a)-ol-11, 17-dione
(a) Possesses 1/10 the androgenic activity
of testosterone. Isolated from urine of
normal28 and castrate men,86 normal34 and
castrate women,99 girl249 and women156 with
adrenal tumor, pregnant women,147 girls with
adrenal hyperplasial56 and a man with an
interstitial cell testicular tumor.233 Demon-
strated to be a metabolite of testosterone and
(g). Source of precursor: adrenal cortex and
testide.
(b) Possesses no androgenic activity. Is an
isomer of (a). Isolated from urine of normal
and castrate men,36 normal women,35 girls
and women with adrenal tumor156 and
hyperplasia.156 Demonstrated to be a
metabolite of testosterone and (g). Source
of precursor: adrenal cortex and testicle.
(c) Possess ¼4 the androgenic activity of
androsterone.5 Isolated from urine of girl
with adrenal tumor249 and girl with "vir-
ilism."55 May be the dehydration product
of (d).
(d) Possesses ¼ the androgenic activityof
androsterone.'68 Isolated from urine of girls
and women with adrenal tumor or hyper-
plasia156 and from urine of normal men.135
Also, from girl with ttvirilism."'163 Likely
source of precursor: adrenal cortex.
(e) Biological action unknown. Isolated
from urine of normal men and women;1'3
also isolated from urine of certain patients
with breast and prostatic carcinoma, with
lymphatic leukemia, with "adrenogenital"
and Cushing's syndrome.139 Probably repre-
sents a normal metabolic product of one or
more of the adrenal steroids.
(I) A9:11 etiocholen-3(a)-ol-17-one (f) Biological action unknown. May be a
dehydration product of the hypothetical sub-
stance, etiocholane-3 (a),l1(,8)-diol-17-one.
Isolated from urine of "a patient with breast
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2. 3-Beta (,8), 17-ketosteroids
(digitonin precipitable)
(g) dehydroisoandrosterone
(A5 androsten-3(,8)-ol-17-one)
(h) isoandrosterone
(etiocholan-3 (,B)-ol-17-one)
carcinoma, certain patients with prostatic
carcinoma, lymphatic leukemia, essential
hypertension, and Cushing's syndrome;" also
from two persons, 76 and 72 years of age,
without known disease. Has not been de-
tected by the same investigators in individual
or pooled collections of urine from normal,
younger men and women.49 The significance
of this finding remains to be determined.
(g) Possesses 1/3 the androgenic activity
of androsterone. Castrate men excrete
amounts greater than normal men,36 excreted
by normal34 or castrate women,100 marked
excess usually excreted in adrenal tumor42
and slight excess in adrenalhyperplasia.42 Has
never been demonstrated to be a metabolite
of testosterone. Source undoubtedly the
adrenal cortex alone but unknown whether it
arises as such, or from some precursor.
(h) A weak androgen. An isomer of (a).
Isolated in small amounts from urine of
normal women'83 and women with adrenal
hyperplasia.31 Demonstrated to be a minor
metabolite of testosterone in man.52 Thecom-
pound has not been frequendy isolated and,
when found, has been present in small
amounts.
B. Ketonic:Non-alcoholic (Probably all artifacts derived during acid hydrolysis)
(i) A3' 5 androstandien-17-one
(j) A2 or A3 androsten-17-one
(k) 3-chloro A5 androsten-17-one
C Non-ketonic:Alcoholic
(1) A5 androstene-3(/3),16,17-triol
(i) A weak androgen. Isolated from urine
of "normals,"48 ovariectomized women,99
man27 and girl249 with adrenal tumor, and
women with adrenal hyperplasia.48 Un-
doubtedly a dehydration product of (g).
(j) Isolated from urine of ovariectomized
women,100 normal men,48 and women with
adrenal hyperplasia.48 Shown233 to be a de-
hydration product of (a).
(k) Isolated from various urines by many
investigators.34 Arises during hydrolysis of
(g) with hydrochloric acid.
(1) Isolated from urine of a boy with
adrenal carcinoma and liver metastases'0l and
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(Table 5 Cont.)
a women156 with adrenal tumor. May be a
metabolite of dehydroisoandrosterone but,
if so, it is remarkable that it has been so
rarely isolated.
(m) A5 androstene-3 (A8),17(a)-diol (m) Isolated from urine of women156, 201
and aboy'02 with adrenal tumor. Shown to be
a metabolite of dehydroisoandrosterone in a
male with anterior pituitary insufficiency.'55
(n) Etiocholane-3 (a),17-diol (n) Isolated from urine of normal men.29
Chemical nature of the individual steroids isolated from normal and
abnormalurine
In Tables 5, 6, and 7 are listed the various individual steroids which
havebeen isolated from normal and abnormal urines. It is to be expected
that further investigations will reveal an even greater variety of com-
pounds. The urinary androstanes and etiocholanes (C19 steroids) are
listed in Table 5; the pregnanes (C21 steroids) in Table 6. Because
technics of isolation have varied with the investigator, the relative
quantities of substances isolated have not been listed. In Table 7 an
effort is made to compare steroid excretion with certain clinical
states. It is noted that the greatest variety of substances has been found
in cases of adrenal tumor and hyperplasia; this may be due to the fact
that urines from these patients have been more thoroughly studied than
urines from other sources. The pertinent, detailed data relating to
the individual steroids are given in the tables. The most striking
feature presented by patients suffering from adrenal cortical tumor is
Table 6
KETONIC AND NON-KETONIC ALCOHOLIC PREGNANES (C21 STEROIDS) AND AN ESTRANE WHICH
HAVE BEEN ISOLATED FROM NORMAL AND PATHOLOGICAL HUMAN URINES
Remarks Compound
1. Pregnane-3 (a),20(a)-diol 1. The main metabolite of progesterone281
in humans. See discussion elsewhere in text.
Frequently found in increased amounts in
patients with "adrenal hyperplasia"'56 or
adrenal tumor.'56
2. Pregnane-3(p3),20(a)-diol 2. Isolated from urine of patients with
"adrenal hyperplasia."'56
3. Pregnane-3 (a),17,20-triol 3. Isolated from urine in one of six patients
with adrenal tumor and three of four patients
with "adrenal hyperplasia."'56 Also isolated
from other cases of "adrenal hyperplasia."'31
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4. A5Pregnene-3(/3),20(a)-diol
5. A5 Pregnene-3(83),17(,B)-diol-20-one
6. Pregnane-3 (a),17-diol-20-one
7. Estrone (C18 steroid)
4. Isolated from urine of a woman201 and a
boy'02 with adrenal tumor.
5. Isolated from urine of a boy with adrenal
tumor.'03 Important because the first A5
compound isolated having an oxygen func-
tion at both C-17 and C-20. Relation to the
common urinary A5 compound, dehy-
droisoandrosterone discussed.'03
6. Isolated from urine of a woman with
"adrenal hyperplasia," a woman with an
adrenal tumor, a crytorchid male and a
eunuchoid male receiving testosterone.'38
Compound not found by same investigators
in urine of normal males or females or
pregnant females. Can be oxidized in vitro
to the common urinary 17-ketosteroid,
etiocholan-3 (a)-ol-17-one.
7. Of all urines investigated from patients
with adrenal tumor or hyperplasia this com-
pound isolated only once.156
the large quantities of dehydroisoandrosterone that have been isolated.
Also, etiocholan-3(a)-ol-17-one and pregnane-3(a),20(a)-diol are
commonly found in increased amounts in these cases. Excessive quanti-
ties of these three substances are not as consistently observed in patients
with "adrenal cortical hyperplasia."* On the other hand, androsterone
and pregnane-3 (a),17,20-triol appear to be found more consistently
in patients with "hyperplasia." When one examines Table 7, it is ap-
parent that no single steroid can be considered completely characteristic
ofeither tumor or"hyperplasia." Individual cases exhibitgreat variations
in their qualitative and quantitative elaboration and excretion of
hormones.'56 When these important studies were undertaken it was
hoped that the characterization of the excreted substances would pro-
vide a better understanding of the intermediary metabolism of the
steroid hormones as well as give helpful information in the difficult
clinical task of differentiating cases of adrenal tumor from hyperplasia.
Unfortunately, as yet it cannot be said that these hopes have been
entirely realized by these methods.
Clinicalconditionsassociatedwith abnormal amounts ofsteroids in urine
Before the level of excretion of 17-ketosteroids can be utilized as an
* It should be noted in these cases that the "hyperplasia" was associated with virilism
and not with the manifestations of Cushing's syndrome.
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index of abnormal endocrine function, normal standards must be
established. Normal children before 7 years of age excrete very little 17-
ketosteroid (average: 1.3 mg. per 24 hours); from then until puberty
there is a gradual increase which is essentially the same in both sexes
andwhichvaries directlywith chronological age and maturity, especially
with the latter. 73' 222 From 11 to 18 years the steroid excretion gradually
assumes adult proportions and the slight differences in excretion be-
tween the sexes become apparent. Normal adult women excrete from
Table 7
STEROIDS ISOLATED FROM NORMAL AND PATHOLOGICAL HUMAN URINES
Ovariec-
Compoand Normal Normal Casrate tomized Adrenal "Adrenal
male female male female tamor hyperplasia"*
Androsterone
Etiocholan 3(a)-ol-17-one
A1' androsten 3(a)-ol-17-one
Androstane 3(a),11-diol-17-one
Etiocholan 3(a)-ol-11,17-dione
A9:11 etiocholan 3(a)-ol-17-one49
Dehydroisoandrosterone
Isoandrosterone
A3'5 androstandien-17-one
A2 or Al androsten-17-one
A5 androstene 3(f3),16,17-triol
A5 androstene 3(,Q3),17(a)-diol
A5 pregnene 3(,B),20(a)-diol
Etiocholan 3(a),17-diol
Pregnane 3(a),20(a)-diol
Pregnane 3(a),17,20-triol
Pregnane 3(8),20(a)-diol
A5 pregnene 3(a),17(/8)-diol-20-one
Pregnane 3(a),17-diol-20-one
Estrone
+ + + + + +
+++++ ± +?
+ ± +
+ + + + + +
+ +
+ + + + +
+ + +
+
+ +
+
+
+ + + +_
+ ±_
+ +
+k +
* Virilism was present in all of these patients; none had Cushing's syndrome.
5 to 17 mg. of 17-ketosteroids per 24 hours, with an average excretion
of about 9 mg. Normal adult men excrete from 6 to 25 mg., with an
average excretion of about 13 mg.62 73 76, 104 Although data on elderly
individuals are distinctly limited, it would seem that there is a slight
decline from these normal levels after the sixth decade of life.'68 202
i
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Different investigators, using various modifications of similar technics,
do not report identical results for normal levels of excretion. However,
the variations in the results from one study to another are small and
generally do not differ by more than 2 or 3 mg. On the basis of these
normal values it is apparent that males excrete, on an average, about
4 mg. more of these steroids per 24 hours than do females. However,
the normal range of excretion is wide and there is great overlapping
of the values obtained from normal men and women. Surely on the
basis of 17-ketosteroid excretion one cannot classify a urine as male
or female in type.
It would appear that the 17-ketosteroid excretion is not absolutely
constant from day to day in the same individual;242 however, the fluctua-
Table 8
CONDITIONS ASSOCIATED WITH ABNORMAL LEVELS OF TOTAL 17-KETOSTEROIDS IN URINE AND
CERTAIN ENDOCRINE DISORDERS ASSOCIATED WITH NORMAL LEVELS OF 17-KETOSTEROID
increased amts. of
17-KS i urine
1. Functioning Adrenal Cortical
Tumor
(see Table 10 and text)
2. Pre-pubertal virilism
(adrenal hyperplasia?)
(see Table 12 and text)
3. "Adrenal" tumors of ovary124
4. Interstitial cell tumor of tes-
tical2a3
5. Some hirsute, post-pubertal
females
(see Table 13 and text)
6. Certain cases of acromegaly
(see Table 15)
7. "Constitutional" or "natural"
sexual and somatic precosity
(slight increase of 17-KS)
(see text)
Decreased amts. of
17-KS in urine
1. Chronic stresses of diverse
types,68 (e.g. infections,malnu-
trition, etc.)
2. Extremes in age217
3. Anterior pituitary insufficiency
(see Table 15)
4. Addison's disease
(see Table 15)
5. Myxedema, spontaneous and
secondary
(see Table 15)
6. Acute and chronic liver dis-
ease73, 79
7. Anorexia nervosa
(see Table 15)
8. Some hypogonad males243
Essentially normalamns.
of 17-KS in ufine
1. Cushing's syndrome, not due
to functioning adrenal tumor.
(see Table 11 and text)
2. Ovariectomized women78
3. Most cases of acromegaly
(see Table 15)
4. Most hypogonad males248
5. Most hirsute, postpubertal
females
(see text and Table 13)
6. Arrhenoblastoma of ovary?
(see text)
7. Male pseudohermaphroditism
85, 97
8. Normal pregnancy230
Artificial or Induced
Increase by:
1. Testosterone or testosterone propionate38
2. Androsterone72
3. Dehydroisoandrosterone72
4. A4 androsten-3, 17-dione72
5. A5 androsten-3 (p), 17 (a) diol diacetatel62
6. Androstane-3 (a), 17(a) diol diacetate72
7. Castration (?)202
8. Adrenocorticotrophic hormone159
Artificial orInduwced
Decrease by:
1. Methyl testosterone19l
2. Certain other 17-methyl steroids72
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tions are not great and according to Talbot and Butler,217 "the chances
are two to one that a single assay will fall within 15 per cent of the
17-ketosteroid value obtained by averaging 30 or 40 consecutive daily
assays." This statement undoubtedly holds true for normal levels of
excretion; however, fluctuations greater than 15 per cent are fre-
quently seen when very low levels of excretion, and occasionally when
distinctlyelevated levels arepresent.60
In Table 8 an effort was made to present in summarized form the
various clinical disorders which have been associated with abnormal
or normal levels of 17-ketosteroid excretion. Available data on the
"corticosteroid" excretion in similar clinical states are summarized in
Table 9. Certain but not all, of these conditions will be dealt with in
detail and with supplementary data. Since the methods used for the
assay of the "corticosteroid" fraction has varied with the investigator,
reference should be made to the original articles to obtain the normal
levels of excretion.
Table 9
CONDITIONS ASSOCIATED WITH NORMAL AND ABNORMAL LEVELS OF
"GLYCOGENIC CORTICOSTEROIDS" IN URINE
(Preliminary survey of existing data)
Essentially
Increased amounts Decreased amounts normal amounts
1. Functioning adrenal cortical 1. Anterior pituitary insufficiency. 1. Pre-pubertal virilism.
tumor with symptoms of Cush- Decreased in 11 of 12 cases (? adrenal hyperplasia)
ing's syndrome 216, 232 5 cases216
(2 cases216) 2. Addison's disease. 2. Hirsute, post-pubertal females.
2. Cushing's syndrome not due to Decreased in 15 of 21 cases 7 cases216,232
adrenal cortical tumor. In- 216, 232 3. Acromegaly; normal in 3 cases,
creased in 14 of 15 cases216. 232 3. Myxedema. increased in 1232
3. Acute and chronic trauma Decreased in 2 cases216
(operations, burns)216 4. Anorexia nervosa.
Slight decrease in 3 cases232
Induced increase by administration of adrenocorticotrophic hormone to a normal female159 and a
male with anterior pituitary insufficiency.227
Functioningadrenalcorticalneoplasmsanddisorders
producingsimilarclinicalphenomena
Clinical aspects: Detailed descriptions, with different methods of
classification, of the varied clinical manifestations of adrenal cortical
neoplasm may be found in reviews by Haymaker and Anderson,92
Kenyon, Parkes,180 Cahill,32 Albright,2 Gross,81 Kepler and Keat-
ing122 and Kepler and Mason.123 It would seem that no method of
clinical categorization is completely satisfactory when dealing with
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certain specific cases. However, the classification proposed by Kenyon
would seem to be mostgenerally applicable. For the sake of convenience
and clarity, conditions, other than adrenal tumor, which give rise to
similar clinical phenomena will be introduced, by notations, directly into
the outline. Problems in differential diagnosis then become apparent.
Kenyon proposed that the syndromes due to adrenal tumor could be
classified roughly as follows: I. The adrenogenital syndrome. II. Cush-
ing's syndrome. III. Intergrades between types I and II. IV. Isolated
expressions of the neoplasm. V. Feminization in adult men and rarely
in children. VI. Tumors without endocrine manifestations.
I. The so-called adrenogenital syndrome is characterized by heter-
ologous sexual precosity in girls, homologous sexual precosity in boys,
andsomatic precosity inchildren of both sexes; and by intense masculini-
zation of adult females. "Over-masculinization" has not been described
in adult males suffering from adrenal neoplasm. So far as is known
Crooke's hyalinization of the basophilic cells of the anterior pituitary
is not apparent in the adrenogenital syndrome,225 nor is contralateral
adrenal atrophy commonly observed.32 Although almost all young girls
suffering from adrenal tumor present a picture of marked virilism,
there are a few cases which have shown vaginal bleeding preceding or
simultaneously withthe symptoms of heterosexual precosity,87 192 237
Remarks: Conditions to be differentiated in girls: (1) Clinical
syndromes of precocious development and virilism similar to those
produced by adrenal cortical neoplasm have been described, associated
with bilateral "adrenal cortical hyperplasia." These cases are sometimes
classified as cases of "pre-pubertal virilism" or as "feminine pseudo-
hermaphrodites" if the virilism is antenatal in origin and gross de-
velopmental defects of the genital organs exist. Clinical differentiation
between these cases and cases of adrenal tumor is difficult or impossible,
especially if the virilism develops after birth. (2) Granulosa cell tumors
of the ovary may cause slight somatic precosity, but the major mani-
festations are an enlarging mass in the pelvis; hypertrophy of breasts,
nipples, and labia; and estrogen-induced, anovulatory "menstruation."
Except for slight genital hirsutism there is no masculinization (large
clitoris, masculine contour, etc.). Hence, differentiation from cases of
adrenal cortical tumor usually is not difficult.'77 (3) Rarely in girls,
certain cerebral lesions (tumors or inflammation) in the region of
the hypothalamus and third ventricle may cause accelerated somatic
development, precocious maturation of the genitalia (adhering to the
sex of the child), breast enlargement, and occasionally "menstrua-
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tion."14, 70 Virilism and heterologous sexual precosity are not seen.
(4) Arrhenoblastomas, apparently purely virilizing ovarian tumors,
have not been reported in individuals less than 15 years of age.177
(5) Homologous sexual precosity in girls has been described asso-
ciated with skin pigmentation and polyostatic fibrous dysplasia of
bones.4 The etiologic interrelationships between these manifestations
are not clear.209' 224 The precosity may be due to hypothalamic lesions.3
(6) "Natural or constitutional" sexual and somatic precosity in girls is
known.86' 176 In these none of the above abnormal conditions are mani-
fest, development is along sexually homologous lines, and excellent
evidence of true ovulation is present in some cases. Even pregnancies
at6 and 9 yearsofagehavebeendescribed.59 176 Apremature awakening
of a normal process is likely.
Conditionsto bedifferentiatedin boys: (1) Somaticandhomologous
sexual precosity (macrogenitosomia praecox) is rarely seen in boys
with bilateral "adrenal cortical hyperplasia.")218' 245 Clinical differentia-
tion from adrenal cortical tumor is impossible. (2) An interstitial
cell tumor ofthe testicle may produce a similarpicture.'93 The palpation
of a scrotal mass should make the diagnosis. (3) More commonly
than in girls, cerebral lesions (pineal tumors, mid-brain and hypo-
thalamic tumors, and inflammations) may cause accelerated somatic
and genital development in boys.50 105, 135 (4) "Natural or constitu-
tional" precosity is rare but has been described.86 In these cases cerebral,
testicular, and adrenal cortical lesions must be excluded.
Conditions to be differenetiated in women: (1) Virilism in varying
degrees (usually only hirsutism) in post-pubertal women is frequently
encountered. In some cases "adrenal cortical hyperplasia" has been
described, but in many the adrenals appear grossly and microscopically
normal. Certain of these patients have a strong family history of
hirsutism and hence the abnormality may be genetically determined.
Most of these patients are not defeminized, have essentially normal
menses, and bear children. At times, however, differentiation from
adrenal cortical tumor may be difficult. (2) Arrhenoblastomas,177
occurringusually in the third decade of life, are strictly virilizing ovarian
tumors which cause defeminization (breast atrophy, amenorrhea, loss
of feminine contour) and masculinization (deepening of voice, hirsu-
tism). Apparently these tumors do not cause the development of the
stigmata of Cushing's syndrome (see below). Differentiation from the
adrenogenital syndrome due to adrenal neoplasm is difficult; the finding
of a pelvic mass is necessary for a positive pre-operative diagnosis. (3)
58SIGNIFICANCE OF URINARY STEROIDS
"Adrenal-like" ovarian tumors are known.124 Histologically they are
differentfrom arrhenoblastomas andappearto arisefrom adrenalcortical
rests. Physiologically they behave like adrenal tumors and may give
rise to any of the clinical and laboratory phenomena associated with
adrenal neoplasm.
II. Cushing's syndrome, characterized, in its full-blown aspects, by
facial and abdominal obesity, thin arms and legs, purple striae and
ecchymoses, plethora, hypertension, osteroporosis, diminished carbo-
hydrate tolerance, and muscular weakness. Polycythemia and a peculiar
hypochloremic alkalosis have been described in some cases. Signs of
virilism in women and children are mild and are represented by slight or
moderate hirsutism. Complete amenorrhea, however, is almost in-
variably present in women. Adrenal cortical neoplasm associated with
Cushing's syndrome is most commonly seen in adult women, and less
commonly in children of either sex and in man. Contralateral adrenal
atrophy is usually present.32
Remarks: Cushing's syndrome in adults frequently is not associated
with a unilateral adrenal cortical neoplasm. Of 98 cases of Cushing's
syndrome reviewed by Thompson and Eisenhart22" 76 were not asso-
ciated with adrenal cortical neoplasm. Pathological lesions reported in
such cases have been "adrenal cortical hyperplasia," or adenomas of the
pituitary (usually, a basophilic adenoma) with or without evident
"adrenal cortical hyperplasia."225 Occasionally no gross lesions are ap-
parent in any endocrine gland.228 However, regardless of the nature or
even absence of associated lesions, cases of Cushing's syndrome almost
invariably exhibit Crooke's hyalinization of the basophils of the
anterior pituitary.40 Also, microscopic lesions in the paraventricular
hypothalamic nuclei have been consistently observed by Heinbecker in
cases of Cushing's syndrome not associated with adrenal cortical
neoplasm.94
III. Intergrades between Types I (adrenogenital syndrome) and II
(Cushing's syndrome). For example, an intensely virilized woman with
facial and abdominal obesity and hypertension. Children with adrenal
tumors usually tend to fall into this "mixed" group.
IV. Isolated expressions of the neoplasm. Although these cases are
unusual, either diabetes211 or amenorrhea238 has been reported as repre-
senting the sole manifestation of the adrenal tumor.
V. Feminization of adult men has been observed in a few cases; in
these, testicular atrophy, impotence, some loss of body hair, and breast
enlargement have been described.'37 140 As stated earlier, vaginal, and
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hence presumably uterine, bleeding has been seen in a few young girls
suffering from adrenal cortical neoplasm.
VI. Adrenal cortical tumors without endocrine or metabolic mani-
festations are known.32
Steroid excretion in adrenal tumor: In Table 10 are given the total
17-ketosteroid excretions and the per cent of the total represented by
the beta fraction (digitonin precipitable) that have been reported in
47 individuals suffering from adrenal cortical neoplasms. Only those
cases of tumor which have had chemical assays for steroids are in-
cluded. For purposes of comparison the levels of excretion are arranged
in ascendingorder and the patients are grouped according to their major
Table 10
THE EXCRETION OF 17-KETOSTEROIDS IN PATIENTS WITH ADRENAL CORTICAL TUMOR (NEOPLASM)
Total 17-keto- Approx. % of total
Author and case Sex and age steroids in 17-ketosteroids as sn years mgm./24 hours p-ftraction
I. Cases of adrenal tumor associated with clinical evidence of intense masculinization but
without the major metabolic stigmata of Cushing's syndrome (e.g., those cases
without hypertension, osteoporosis, or diabetes).
1. Callow and Crooke, case 437 Female,41 76, 78 no data
2. Johnson and Nesbit, case 1112 Female, 31 78.5 79
3. Johnson and Nesbit, case 2112 Female, 2 75 73
4. Hain, case 584 Male, 10 84 no data
5. Callow and Crooke, case 337 Female, 26 107 no data
6. Talbot et al., case 15a218 Female 133 50
7. Talbot et al., case 9222 Female, 3 160 65
8. Fraser et al., case 4073 Female,3½2 176 (av.) no data
9. Hain, case 384 Female,4 320,166 no data
10. Bauman et al., case K12 Female, 25 367 30
11. Engstrom et al., case 863 Female,45 857 no data
II. Cases of adrenal tumor associated with definite Cushing's syndrome and with minimal
virilism.
12. Fraser et al., case 3573 Female, 36 19.9* no data
13. Kepler and Mason, case 16123 Female,40 30 7.5
14. Crooke and Callow, case 142 Male, 25 40-64 20
15. Hain, case 184 Female, 21 45 no data
16. Callow and Crooke, case 537 Female, 38 54,52 no data
17. Fraser et al., case 3473 Female, 56 72 no data
18. Talbot et al., case 14218 Female,56 74.0 22
19. Wilhelm and Gross244 Male,46 92.7 no data
20. Engstrom et al., case 563 Female,25 131 no data
21. Patterson et al., case 3182 Female, ? 170 no data
22. Crooke and Callow, case 242 Female,6 126-288 65
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23. Patterson et al.,case 4182
24. Kepler and Mason, case 14123
Female, 34 270
Female, 53 800 (av.)
111. Cases of adrenal tumor associated with various degrees of masculinization and of the
manifestations of Cushing's syndrome and cases where the available data do not
warrant categorization.
25. Engstrom et al., case 163
26. Engstrom et al., case 263
27. Kepler and Mason, case 17123
28. Hain, case 284
29. Callow and Crooke, case 137
30. Patterson et al., case 2182
31. Patterson et al., case 1182
32. Friedgood and Whidden76
33. Engstrom et al., case 363
34. Engstrom et al., case463
35. Kepler and Mason, case 18123
36. Warren, case 66239
37. Johnson and Nesbit, case 3112
38. Warren, case 99239
39. Talbot et al., case 10222
40. Engstrom etal., case 663
41. Anderson et al.9
42. Engstrom et al., case 763
43. Warren, case 79289
44. Friedgood and Whidden76
45. Hirschmann10l
46. Warren, case 75239
47. Kepler and Mason, case 15123
Male, 1 ¼4
Female, 1 ¼4
Male, 39
Female, 3½V2
Female, 61
Male, 5
Male, 1
no data
Female, 63
Female, 16
Male, 32
Female, 54
Male,43
Female,40
Female, 13
Female, 3 ½2
Female, 25
Female, 21
Female, 49
no data
Male, 7
Female, 42
2.8
t 3.0
4.8**
5.9
14.5, 20***
27
28(per1.)
45
45
54
68
83
86
126
166
170
215
240
269
325
275,420
690
Female, 55 1005
no data
no data
no data
no data
no data
no data
no data
no data
no data
no data
48
no data
57
no data
50
no data
no data
no data
Isolated dehydro-
isoandrosterone
but not quant.
no data
No quant. data
Isolated dehydro-
isoandrosterone
but not quant.
77
* Urine stored 5 years before assay.
* Probably a non-functioning adrenal cortical tumor.123
* Patient "extremely ill" at time of urine collection.37
clinical manifestations, i.e., those with the so-called adrenogenital
syndrome, those with Cushing's syndrome, and those that could not be
assigned toeither group. Only 10 of the 47 patients were males. Thirteen
cases of tumor in children are reported; 5 in boys and 8 in girls. Al-
though some of the values for total 17-ketosteroid excretion in young
children are below the average range for normal adults, the values
are consistently above the average for normal children of comparable
age. Difficultproblems in differential diagnosis arise when only moderate
no data
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elevationsoftotal 17-ketosteroid excretion occur, e.g.,when patientswith
adrenal neoplasm excrete less than 50 mg. per 24 hours. Eight cases of
tumor in adults have been reported to exhibit excretions in this range
(cases 12, 13, 14, 15, 27, 29, 32, and 33). Although not with certainty,
theresults inthreeofthesecases (12, 27, and 29) may have been funda-
mentally erroneous or misleading. In case 12 the urine had been
stored for 5 years before assay, case 27 probably had a non-functioning
adrenal tumor, and case 29 was moribund at the time of urine collection.
Thus, if the results in these three cases can be disregarded then all of
the patients with functioning adrenal cortical tumor excreted more
than normal amounts of ketosteroids. However, 5 of the adults un-
equivocally excreted less than 50 mg. per 24 hours (i.e., amounts which
are not greatly excessive). Although many patients excreted more than
100 mg., almost an equal number had values between 50 and 100 mg.
In only 14 of the 47 cases was the 3-beta-alcoholic fraction deter-
mined. Normally, the beta steroids comprise about 5 per cent of the
total 17-ketosteroids. In all but one instance this fraction was distinctly
or markedly elevated (e.g., up to 79 per cent). The exception (case
13) is important since it indicates than an adrenal neoplasm may be
present in spite of a normal value for the beta fraction. The patient
had Cushing's syndrome and a rather low total 17-ketosteroid excretion.
Itisinterestingthat the levels ofsteroid excretion in patients that are
intensely masculinized (adrenogenital syndrome) are not significantly
different from the levels seen in those that present the manifestations of
Cushing's syndrome. Undoubtedly, factors other than the extent of
elaboration (or at least, of excretion) of androgenic steroids are in-
volved in the pathogenesis of these syndromes. Certainly one cannot
conclude that in those cases of tumor associated with the adrenogenital
syndrome androgen elaboration (anabolic steroids?2) was sufficiently
great to prevent the development of Cushing's syndrome. The latter
patients appeared to elaborate quite as much androgen (as measured by
17-ketosteroid excretion) as the former.
It should be noted that none of the 5 adult males herein reported
showed definite evidences of feminization, although case 19 was re-
ported to be impotent and to possess small soft testicles. Two of the
adultmalepatients (cases 14 and 19) presented thepicture ofCushing's
syndrome; three (cases 27, 35, and 37) showed no evident endocrine
or metabolic abnormalities in spite of the fact that cases 35 and 37
showed moderate, but not greatly excessive, increase in 17-ketosteroid
output. All of the adult females and all of the children in this series
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showed evidences of disturbed endocrine function (see references for
details).
Steroid excretion in Cushing's syndrome not due to adrenal tumor:
Since certain other pathological states may be associated with clinical
syndromes that are similar to or identical with those produced by
adrenal cortical tumor, the steroid excretions in some of these states will
be considered. The values for the excretion of 17-ketosteroids in 36
patients with Cushing's syndrome proven not to be associated with
adrenal neoplasm are given in Table 11. At least half of these cases
Table 11
THE EXCRETION OF 17-KETOSTEROIDS IN PATIENTS WITH CUSHING'S SYNDROME
PROVEN NOT TO HAVE ADRENAL CORTICAL TUMOR (NEOPLASM)
Autbor and case
1. Callow and Crooke, case 737
2. Kepler and Mason, case 22123
3. Fraser et al., case 3773
4. Venning and Browne, case 17232
5. Talbot et al., case 7222
6. Venning and Browne, case 21232
7. Venning and Browne, case 19232
8. Fraser et al., case 3873
9. Crooke and Callow, case 342
10. Deakins et al.,46
11. Talbot et al., case 6222
12. Callow and Crooke, case 837
13. Fraser et al., case 3673
14. Callow and Crooke, case 637
15. Kepler and Mason, case 20123
16. Kepler and Mason, case 21123
17. Callow and Crooke, case 937
18. Pashkis et al.,18'
19. Warren,239 17 cases
20. Warren, case 122239
Sex and
age in years
Female, 28
Female, 26
Female, 26
Female, 33
Female, 26
Male, 27
Male, 11
Female, 43
Female, 12
Female, 15
Female, 43
Female, 30
Female, 49
Female, 39
Female, 27
Male, 29
Female, 43
Female, 28
Females
Male, 34
7.5
10.0
10.4
10.0, 8.1
11.2
11.0
11.5
11.5
11, 18.6
11, 20
14.8
18.5
19.7
20.2, 21
24
28
28.5
31
6-37(mean:18.6)
33.2.
* It is not possible to state regarding this patient whether or not the surgically removed
"benign adenoma" was a functioning, neoplastic primary adrenal tumor since the opposite adrenal
also contained a small cortical adenoma at autopsy. Basophilic adenomas of the anterior pituitary
associated with Cushing's syndrome frequently exhibit "cortical adenomas" and/or adrenal
hyperplasia.225
have total excretions that arewithin the range of normal. The remainder
excrete moderately increased amounts; however, none of the values
reported are greater than 50 mg. per 24 hours. When these results are
Total 17-keto- Approx. % of tota;
steroids in 17-ketosteroids as
mgm./24 bours p-fraction
no data
5
no data
no data*
12
no data
no data
no data
none isolated
no data
7
no data
no data
no data
14
2
no data
no data
no data
no data
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compared with those obtained in patients with adrenal tumor the fol-
lowing tentative conclusions might be reached concerning adults with
Cushing's syndrome: If normal amounts of total 17-ketosteroids are
excreted, a unilateral, functioning adrenal cortical neoplasm would not
be expected to exist; if the amounts are increased above normal but
below 50 mg. per 24 hours, the chances are at least 6 to 1 that the
syndrome is not associated with adrenal cortical tumor; if values are
consistently above 50 mg., the data would support a diagnosis of tumor.
Also, in view of the lack of precise criteria for establishing a diagnosis,
it would seem that any individual with Cushing's syndrome who is
excreting more than normal amounts of 17-ketosteroids deserves sur-
gical exploration of the adrenal areas for tumor.
Thepercentofthetotalketosteroids represented by the beta-fraction
has been determined in a few cases of Cushing's syndrome not due to
adrenal neoplasm. In noneofthese was the beta-fraction greater than 20
per cent. This finding is in sharp contrast with the results obtained in
patients with tumor. Hence, the determination of the beta-fraction may
provide additional aid in differential diagnosis. However, more data are
necessary before rigid criteria are formulated to differentiate those cases
due to tumor from those without it. From the available information,
a distinctly elevated beta-fraction (e.g., above 40 per cent) would
support a diagnosis of tumor, while a moderate increase (e.g., 10 to 20
per cent) would not necessarily rule out tumor (see cases 13, 14, and
18, Table 10).
Steroid excretion in pre-pubertal viriism: Difficulties in differential
diagnosis also arise when dealing with certain cases of pre- and post-
pubertal virilism in females. In Table 12 are summarized the 17-
ketosteroid excretions that have been recorded in 31 patients with pre-
pubertal virilism associated with proven "adrenal cortical hyperplasia,"
adrenal tumor having been ruled out. The data were arranged accord-
ing to the chronological age of the patient at time of assay. Some of
these patients were categorized by the authors as feminine pseudo-
hermaphrodites, since these children were born with genital abnormali-
ties (e.g., enlargement of the clitoris, external urethra opening at the
base of the "penis," a rudimentary vagina, hypoplastic uterus, etc.).
In general, these infants do not thrive but if they do, the females be-
come chronically masculinized, never menstruate, and finally become
rather stunted in growth. Occasionally these children are reared as
boys. In the other cases evidences of virilism developed some time after
birth butbeforepuberty. The older individuals had symptoms that dated
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back to childhood. In the majority of these latter patients the major
clinical manifestations were those of virilism (hirsutism, deep voice,
muscular, hypertrophy of the clitoris, and hypoplasia of the uterus),
but without other gross genital abnormalities. Hence, it seemed most
convenient and logical to classify the entire group as "pre-pubertal
virilism." Noneofthesepatients had thestigmataofCushing's syndrome.
It is quite apparent that many of these patients excrete more 17-
ketosteroids than do many patients with adrenal cortical tumor. Values
between 50 and 100 mg. are common, particularly in the older in-
dividuals. Ifone were to use only the 17-ketosteroid excretion as a guide
in the differential diagnosis between tumor and hyperplasia in a
virilized girl, a value well over 100 mg. would be necessary to support
a diagnosis of tumor. When values below 100 mg. are obtained in a
girl who develops virilism after birth the differentiation between tumor
and hyperplasia becomes exceedingly difficult or impossible. Although
the data are limited, it would appear that the determination of the
beta-fraction would be helpful in making this differentiation. This
fraction is generally higher (usually well over 20 per cent) in the
cases associated with tumor than in those with hyperplasia (from zero
to 23 per cent) but some slight overlapping may be observed (see
cases 13, 14, and 18 in Table 10 and cases 11 and 27 in Table 12).
Hence, to diagnose an adrenal tumor unequivocally in this group
would necessitate a total 17-ketosteroid excretion above 100 mg. per 24
hours of which at least 30 per cent are beta-steroids.
One gains the impression that the longer the virilism persists the
greater the ketosteroid excretion becomes; in the table it is noted that
the highest excretions are seen only in the older, and the lowest only
in the younger agegroups. Althoughchance distribution and selection of
cases may account in part for the phenomenon, cases 17 and 27 would
appear to bear out the impression. These cases were studied by the same
investigators 1 and 2 years after the initial determinations, and definitely
higher values were obtained in the later studies. Similar findings have
been reported by Talbot et al.2"8 Except as a "maturation phenomenon"
no ready explanation is available.
Steroid excretion in post-pubertal virilism: A common "endocrino-
logical" problem is that presented by the post-pubertal, hirsute female.
The hirsutism appears at or after the menarche. Almost invariably the
question of adrenal or ovarian neoplasm is raised and almost invariably
none is found. Hirsutism in varying degrees is the common feature of
all these cases; rarely some generalized obesity and/or menstrual dis-
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Table 12
THE EXCRETION OF 17-KETOSTEROIDS IN CASES OF PRE-PUBERTAL VIRILISM WITH PROVEN
ADRENAL CORTICAL HYPERPLASIA AND IN PATIENTS CLASSIFIED AS FEMININE PSEUDOHERMAPH- RODITES IN WHOM VIRILISM AND GENITAL ABNORMALITIES HAVE BEEN PRESENT SINCE BIRTH AND IN WHOM ADRENAL HYPERPLASIA IS HIGHLY PROBABLE OR PROVEN. (ALL THE OLDER PATIENTS HAVE HAD SYMPTOMS DATING BACK TO CHILDHOOD).
Total 17-keto- Approx. %; of total
Author and case Age in years stemomd/ in 17-ketosteroidsas mgm./24 hours p8 fraction
1. Engstrom et al., case 963 3 13.5 no data
2. Genitis and Bronstein, case 278 4 37 no data
3. Engstrom et al., case 1063 5 37 no data
4. Broster, case HA22 5 6 no data
5. Talbot et al., case 4218 5 19.2 17
6. Broster, case BA22 6 12.4 no data
7. Broster, case Eg22 7 37 no data
8. Patterson et al., case 4182 7 37, 34 no data
9. Talbot et al., case 8218 8 11.7 0
10. Talbotet al., case 10218 8 23.4 7
11. Talbotet al., case 1,222 Male 8 17.0 23
12. Patterson et al., case 1182 9 52 no data
13. Patterson et al., case 7182 9 50 no data
14. Genitis and Bronstein, case 178 10 30 no data
15. Kepler and Mason, case 19123 10 31 14
16. Talbot et al., case 2222 11 29 0
17. Genitis and Bronstein, case 178* 11 69 no data
18. Broster, case Mot22 12 32 no data
19. Talbot et al., case 11218 13 23.4 3
20. Patterson et al., case 6182 13 64 no data
21. Broster, case Sim22 16 43 no data
22. Patterson et al., case 3182 17 35 no data
23. Broster et al., case Her22 17 54 no data
24. Patterson et al., case 2182 18 56 no data
25. Patterson et al., case 5182 18 54 no data
26. Engstrom et al., case 1163 19 75.2 no data
27. Kepler andMason, case 1123* 21 123 20
28. Hain, case 1284 21 35-74 no data
29. Broster, case Ron22 22 75 no data
30. Talbot et al., case 4222 23 60 9
31. Engstrom60*** 41 102 (av.) no data
Same case as number 14, observed one year later.
Same case as number 26, observed two years later.
a New Haven Hospital case B93002.
turbances are observed; in none are definite stigmata of Cushing's
syndrome present. In many, the hirsutism appears to be a familial trait.
The data on the 17-ketosteroid excretion in over 130 of these cases are
presented in Table 13. In slightly more than half of these the totalSIGNIFICANCE OF URINARY STEROIDS
Table 13
THE EXCRETION OF TOTAL NEUTRAL 17-KETOSTEROIDS IN WOMEN WITH
POST-PUBERTAL VIRILISM NOT DUE TO ADRENAL TUMOR'
Total 17-ketosteroid fn
Numbet ot Age milligrams per 24 hours
Reference cases Range in years Range Mean
Callow and Crooke37 7 21-44 10.0-30 16.5
Patterson et al.182 67 18-34 6.4-33.4t 19.9
Warren289
"adrenal virilism" 20 19-36 5.9-37 22
"hirsutism" 13 20-36 3.4-33 16
Venning and Browne232 4 16-54 23.1-37 28
Friedgood and Whidden76 21 - 1.0-29§
In these cases adrenal cortical tumor presumably has been excluded but the precise
anatomic and functional status of the adrenal cortex remains uncertain. Although the
adrenal is incriminated in many of these cases, the possibility that the defect resides in the
ovary or elsewhere remains to be considered. Certain of these patients have a strong
family history of hirsutism and hence in such individuals this abnormality may be
genetically determined. Refinements of subclassification with such terms as "adrenal
virilism" seem confusing and unwarranted. Hirsutism is the common feature of all these
cases; less commonly irregular menses or obesity is observed, and rarely amenorrhea.
t Less than half of these cases excreted amounts clearly in excess of normal.
§ The clinical data on these patients are extremely fragmentary.
17-ketosteroid excretion is within the range of normal. In the remainder
moderate elevations are observed; the highest recorded value being
37 mg. per 24 hours. From what is understood of the origin of the
17-ketosteroids some abnormality in adrenal cortical function is likely in
these latter cases. The true nature of the abnormality in those with
normal amounts of 17-ketosteroids in urine is obscure. In those cases of
hirsutism which seem to be familial in origin an abnormal responsive-
ness to normal androgenic influences is possible. Also, it is conceivable
that under certain circumstances androgens may be elaborated by
ovaries or adrenal cortices that are not metabolized to the usual urinary
steroids. Until more precise information is available it would seem
that this group could be best categorized and characterized by such
general terms as "post-pubertal virilism" or "simple hirsutism." The
term "adrenal virilism" implies a knowledge of etiology that is not
generallywarranted.
General remarks regarding "hyperfunctioning" adrenal lesions:
Having thus described the patterns of 17-ketosteroid excretion in condi-
tions classified as being representative of adrenal cortical hyperfuction
(adrenal tumor and "adrenalcortical hyperplasia") certain general com-
ments are needed. As was pointed out earlier other pathological lesions,
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especially in children, may give rise to clinical phenomena identical
with or at leastsuperficially similar to those produced by hyperfunction-
ing adrenal lesions. It is imperative, therefore, that each patient be
studied individually. Hormone assays should be utilized only as an
adjunctto acareful history and physical examination. The family history,
theexactnature ofthe abnormality, the age atwhich it became manifest,
the evidences of cerebral involvement, etc. are all points to be care-
fully evaluated when dealing with problems of sex differentiation. A
family history of hirsutism in a mildly or moderately virilized woman
may be of great importance. Also, certain forms of pseudohermaph-
roditism (especially of the male type) tend to be familial.248
Heterologous sexual precosity (sex inversion) in girls is frequently
associated with hyperfunctioning adrenal cortical lesions (tumors or
hyperplasia) while homologous sexual precosity is not. Homologous
precosity in girls is more commonly associated with cerebral or ovarian
lesions. Children of either sex that show evidences of Cushing's
syndrome in addition to virilism more commonly suffer from adrenal
tumor than not,148 while in adults Cushing's syndrome is more com-
monly associated with pathological lesions of pituitary or adrenal other
than adrenal neoplasm.22"
If on the basis of clinical evaluation and laboratory studies it
appears that a patient suffers from a hyperfunctioning lesion of the
adrenal cortex, a study of the steroid excretion in urine may be helpful
todifferentiate tumor from "hyperplasia." The limitations of this method
have already been noted. However, the differentiation is therapeutically
important since patients with adrenal tumor may be cured of their con-
dition by the surgical removal of the neoplasm. It is not the purpose of
this communication to discuss the theoretical pathogenesis of Cushing's
syndrome (see Albright,2 Kenyon,"7 Kepler,2" and Crooke41) nor to
engage in a discussion of the histology of the adrenal cortical lesions
associated with Cushing's syndrome and virilism. However, since efforts
have been made to compare steroid excretions in different clinical con-
ditions and to view the levels of excretion as expressions of certain
aspects of endocrine function, a few general comments are in order.
So far as the clinical manifestations of adrenal tumors are concerned
it is clear that the age and sex of the patient determines to a certain
extent the type of clinical response. As was pointed out in the intro-
ductory paragraphs, a given response to a hormone depends on the
chemical nature of the administered (or endogenously manufactured)
hormone, the dose, the nature of the transformation products, the
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effects produced in other glands or tissues, and the biological soil on
which the hormone or other products act. The importance of the last
factor is borne out by the observation that adrenal neoplasms do not
always produce identical clinical syndromes in boys, girls, men, or
women. Masculinizing effects of varying degree are one of the most
consistent features of adrenal cortical tumors. Hence it would be
expected that heterologous sexual and somatic precosity would be
observed in girls, homologous precosity in boys, and masculinization in
adult women. No distinct evidences of virilism in previously normal
adult men would be expected since the conditioned, male secondary sex
characters are already fully developed. However, a few cases of adrenal
neoplasm in men'37 140 have been associated with feminization (if
testicular atrophy, impotence, and breast enlargement can be con-
sidered "feminization"). Also, vaginal bleeding, though unusual, has
been observed in girls.87' 192, 237 There are three possible explanations
for these phenomena of feminization. First, it is possible that a true
phenolic estrogen is elaborated in excess by certain adrenal cortical
tumors. Second, excessive amounts of "androgenic" steroids may be
elaborated but these may be partially converted in the body to phenolic
estrogens. That this conversion may occur in the human male is
suggested by the fact that the administration of testosterone propionate
is followed by an appreciable increase in the estrogenic activity of the
phenolic fraction of urine.89 106 It may be pertinent that Forbes"9
demonstrated that testosterone propionate (an androgen shown to
cause lobule-alveolar growth of the mammary glands of monkeys and
rats 67.133) caused mammary gland enlargement in the adult male rat
but not in the pre-pubertal male. However, the biological action of
adrenal "androgen" on the human mammary gland and testis is un-
known. The fact that an estrogen (estrone) has been isolated in
excessive amounts from the urine of a female patient with an adrenal
neoplasm"' can be explained by either of the above two mechanisms.
Third, a tumor may elaborate steroids, e.g., dehydroisoandrosterone,
AS androstene-3,17-diol, which are both androgenic and estrogenic in
activity. The nature of the response would undoubtedly depend on the
age and sex of the patient; feminization or masculinization would
appearonlywhen theseresponses could be recognized (e.g., feminization
in an adult male or child and masculinization in an adult female or
child). In other words, itwould not seem absolutely necessary to believe
that excessive amounts of phenolic estrogens are elaborated by the
tumors in all ofthese cases of "feminization" even though the possibility
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exists. "Androgenic" and "estrogenic" responses are only relative biolo-
gical terms.
From the data on total 17-ketosteroid excretions and from data
obtained by the isolation of the crystalline compounds it is clear that
there probably are great variations in the qualitative and quantitative
elaboration, and surely great variation in the output of steroid hormones
in patients suffering from adrenal tumor. Equally great variations are
observed in the clinical manifestations. However, at least from the data
on the conjugated neutral steroids it has not been possible as yet to
correlate clinical phenomena with any particular pattern of total or in-
dividual steroid excretion. It would seem premature to state that all of
the symptoms of adrenal neoplasm are entirely and directly related to
the nature and amounts of steroid hormones elaborated. For example,
it is not easy to account for all of the manifestations of Cushing's
syndrome on the basis of the known actions of the adrenal steroids.
Efforts along these lines have not been entirely successful.117 Although
the neoplasm undeniably is the basic cause of the disorder, it is likely
that the development of certain of the manifestations depends more on
the resultant secondary effects in other endocrine glands or on certain
peculiarities of the individual than on the direct actions and effects of
the known steroid hormones of the adrenal on biochemical processes.
An adrenal cortical tumor can be considered a pathological entity
without much argument; unfortunately, as much cannot be said for
"adrenal cortical hyperplasia." Adrenal cortical hyperplasia has been
described in several different disorders, e.g., in certain cases of
acromegaly, in Cushing's syndrome without adrenal neoplasm, in pre-
pubertal virilism. There has been no unanimity of opinion as to what
criteria, besides adrenal weight, define adrenal cortical hyperplasia.18
In any event, the fact that "hyperplasia" has been described in Cushing's
syndrome and again in such a different clinical condition as pre-pubertal
virilism can only point to the fallacy of considering the "hyperplasia" a
single functional entity. Even though the histology and weights of
the adrenals may be described as similar in these two different condi-
tions,'8 the nature of the cortical function or dysfunction must be
different in each. On this basis it is likely that the origin of these
states also differs. Only by the utilization of a functional approach will
the difficult problems of pathogenesis be solved. To use the term
"hyperplasia" in a loose sense to denote bilaterally enlarged adrenals, no
matter what the associated clinical state may be, may be useful
terminology in the differentiation of neoplastic from non-neoplastic
70SIGNIFICANCE OF URINARY STEROIDS
adrenal cortical lesions. However, further than this the term has little
meaning at the present time.
Although "adrenal cortical hyperplasia" has been described in
functionally and clinically different conditions, differences in steroid ex-
cretion might be observed in these dissimilar states in spite of similar
pathological lesions. So far as the total- and beta-17-ketosteroids are
concerned some differences are present; though these are not striking
(compare Tables 11 and 12). When comparable age groups are con-
sidered generally much higher total 17-ketosteroid levels are observed
in the congenitally virilized cases than in those with Cushing's syndrome
not due to adrenal neoplasm. However, no differences in the beta-
fraction are noted in the two groups. Unfortunately, a comparison of
the nature of the neutral steroids isolated in crystalline form is not
possible in these two syndromes. As previously noted data are available
for the cases of virilism but the urines of patients with Cushing's
syndrome (not associated with adrenal tumor) appear to have been
neglected, probably because the neutral 17-ketosteroid excretion is
usually not excessive. Thus far mention has not been made of the level
of excretion of the "corticosteroid" fraction in states cotnsidered to be
representative of adrenal cortical hyperfunction. The level of excretion
of this fraction is generally considered to provide a measure of the
glycogenic and other related cortical activities. Although the data are
not extensive, very striking differences are noted between the cases of
"hyperplasia" associated with virilism and those associated with Cush-
ing's syndrome.26' 232 In the latter individuals the "corticosteroid" excre-
tion has been observed to be increased by from 2 to 12 times normal,
while in the former essentially normal amounts were noted.232 Clearly
all of the "hyperplastic" adrenal glands do not function similarly.
In spite of considerable knowledge concerning the experimental pro-
duction of enlarged adrenal cortices in animals and the factors involved
in the control of cortical activity (see introductory paragraphs), the
genesis of "adrenal hyperplasia" in man remains obscure.
Miscellaneous conditionsassociatedwith normalandabnormal
amounts ofsteroidsin urine
Virilizing ovarian tumors. Data on these few cases (Table 14) are
limited to the total 17-ketosteroid excretions. It has not been possible
to determine the precise histological picture of several of these reported
neoplasms and therefore the entire group was categorized as suffering
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from "virilizingovarian tumors." Those tumors inwhich the histological
data are described or stated were considered to be arrhenoblastomas or
adrenal-like tumors. In the past, various names have been used to
characterize the adrenal-like ovarian tumors-terms such as luteomas,
Table 14
VIRILIZING OVARIAN TUMORS
(ARRHENOBLASTOMAS AND ADRENAL-LIKE TUMORS OF OVARY)
17-ketosteroid excretion
in milligrams per 24 hbr.
6.9 (av.)
3.2 (post-op.)
2. Mathiesen (cit. by Pedersen'84) 4.0
3. Abarbanel et al1
4. Jones and Everett,113 case 2
5. Kepler et al.414
40.0 (per liter)
56, 36
11 (post-op.)
54.6
2.6 (post-op.)
Remawks
Age 30, with hirsutism, obesity,
amenorrhea, deep voice, begin-
ning baldness of scalp, enlarged
ditoris. Normal glucose toler-
ance. Recovery after removal of
"arrhenoblastoma."
Age 24. No further data. aassi-
fied as "typical arrhenoblastoma
(tubules)."
Age 22. Amenorrhea developed
at 16 followed by hirsutism,
deepening of voice, and enlarge-
ment of ditoris. No histological
data given.
Age 26. Irregular menses, deep
voice, hirsute, enlarged ditoris,
female bodily configuration,
normal glucose tolerance. No
pregnanediol found in urine.
Classified as "arrhenoblastoma of
intermediate cell type."
Age 16. Amenorrhea, hirsutism
face full and round, headaches,
voice rather low pitched, well
developed musculature, sugges-
tion of "buffalo hump," acne, and
stria present, breasts large and
pendulous, blood pressure
160/110. Normal fasting blood
sugar. Clinical impression: Cush-
ing's syndrome. Tumor dassified
as: "adrenal-like ovarian tumor."
Ausbof and cae
1. Fraser etal.,73 case 102
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6. Hain84 116 Age 12. "Virilizing ovarian
tumor." Clinical and pathological
data not reported.
7. Warren,29case 87 158 Age 31. Virilism developed dur-
ing pregnancy. An "ovarian
tumor removed." No further data
given.
8. Luft (cit. by Pedersen184) 23.8 Age 44.Pronounced virilism."No
metabolic changes." Tumor
diffuse "adrenal-like cells."
9. Pedersen'84 12, 17 Age 50. Amenorrhea, hirsutism,
baldness, seborrhea, acne, clitoris
1.8-8.6 (post-op.) enlarged, deep voice, plethora of
face, breasts normal, questionably
impaired glucose tolerance, no
osteoporosis or hypertension.
Ovarian tumor: "Diffuse, non-
lipoid containing adrenal-like
tumor."
leuteoblastomas, adrenalcorticalcarcinomas, and masculinovoblastomas.
Three of the neoplasms were classified as arrhenoblastomas (cases 1, 2,
and 4); in two, normal amounts of ketosteroids were excreted; in one
excessive amounts. Three of the neoplasms were considered to be
adrenal-like ovarian tumors (cases 5, 8, and 9); in two excessive
amounts and in one, normal amounts of steroids were excreted. What
conclusions can be drawn from these few cases? Although arrheno-
blastomas appear to be strictly virilizing tumors, adrenal-like ovarian
tumors may cause any of the signs, symptoms, and laboratory mani-
festations of adrenal cortical neoplasms (e.g., very high 17-ketosteroid
excretions, Cushing's syndrome, adrenogenital syndrome, etc.). How-
ever, these latter cases are rare; Kepler and Dockerty'24 were able to
collect only 14 cases up to 1943. Since three patients with virilism
and ovarian neoplasm excreted normal amounts of 17-ketosteroids and
since the virilism regressed after surgical removal of the tumor, it
mustbeconcluded that an abnormal human ovary is capable of elaborat-
ing androgen not normally metabolized to 17-ketosteroids. Although
these observations are few in number there is no good reason to believe
that the results were purely fortuitious. In any event these observations
are sufficient to discourage hasty conclusions regarding the adrenal
cortical origin of all cases of hirsutism in females.
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Male pseudohermaphroditism, true hermaphroditism, and "natura
or constitutional" precosity in children. Data thus far reported, though
meager because of the rarity of these conditions, would indicate that the
excretions of 17-ketosteroids are normal or very slightly increased. A
malepseudohermaphrodite can bedefined as an individual whose gonads
are testes but in whom some of the secondary sex characters and genital
organs are female in type. Many of these patients are reared as girls.
The direct cause of feminine pseudohermaphroditism is generally be-
lieved tobeduetoexcessive androgen production by hyperplastic adrenal
corticies, although the cause of the hyperplasia remains unknown; the
genesis of male pseudohermaphroditism, on the other hand, is not
entirely clear. Witschi248 has presented statistical evidence to indicate
that these patients are genetic males, and he suggests that abnormal
maternal hormonal influences (possibly estrogenic) play an important
role in the development of the anomaly. Total 17-ketosteroid excretions
of 10 mg. and 9 mg. were reported by Herweg et al.58' 97 in two male
pseudohermaphrodites aged 15 and 26, respectively; Hain reported
13.3 and 7.4 mg. in a similar patient 14 years of age. If these observa-
tions can be supported by further similar studies it is clear that the level
of the 17-ketosteroid excretion may be a very helpful diagnostic aid
when dealing with cases of doubtful sex. In contrast to the male
pseudohermaphrodites it has already been noted that female pseu-
dohermaphrodites excrete excessive quantities of these steroids.
A true hermaphrodite is an individual with both male and female
gonads; the ovarian and testicular tissue may be separate or fused
(ovotestis). Such patients may be reared either as boys or girls. The
condition is rare and has been reported only 40 times.'1' Weed et al.240
reported a total 17-ketosteroid excretion of 7.6 and 7.5 mg. per 24
hours in a true hermaphrodite 36 years of age.
Hain86 reported the 17-ketosteroid excretions in 5 girls with "con-
stitutional") precosity* to be slightly above the average for their age
in 3 patients and normal in two. In two boys the 17-ketosteroid ex-
cretions were also slightly above normal. In these cases primary adrenal
cortical and gonadal diseases presumably were ruled out and there was
no evidence by history or examination ofgross intracranial abnormality.
*After preparation of the manuscript the author discovered that Nathanson and
Aub (J. Clin. Endocrinol., 1943, 3, 321, reported studies on six children (4 to 8
years of age) with "abnormally early adolescence." The levels of 17-ketosteroid excretion
(from 3.5 to 14.9 mg. per 24 hours) tended to approach values found in older children
and in adults. The amounts excreted appeared to be more directly related to the physical
and skeletal maturity of the patients than to their chronological age.
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Theageofthesepatientsrangedfrom 3.5 to 11 years, and 17-ketosteroid
excretions ranged from 1.4 to 6 mg. per 24 hours. Children with
homologous, precociousdevelopment associated with intracranial lesions
resemble these cases of "constitutional" precosity in many respects.
Although precise data are not available, it is likely that the excretion
of steroids is quite similar in both groups.
Male hypogonadism. Herein will be considered those patients who
show clinical evidences of deficiency of testicular androgen, i.e., those
classified as eunuchs or as eunuchoids; patients with failure of gameto-
genesis only will not be considered. Many difficulties arise when one
endeavors to interpret 17-ketosteroid excretion in conditions associated
with failure of testicular androgen elaboration. Except in castration or
whendealingwith distinctly local testicular disease the origin of the fail-
ure is frequently in doubt. The genesis of the failure is of utmost im-
portance before interpretation of hormone assay can be made. In in-
dividual cases it is frequently difficult to distinguish a "primary" failure
(e.g., a genetic defect in the germ plasm or other) from a "secondary"
failure (e.g., anterior pituitary failure from any cause; past or present
nutritional deficiencies, etc.). Also a deficiency that originates pre-
pubertally wouldnotbe expected to produce the same clinical or labora-
torypicture aswouldonethatoriginates post-pubertally. Gonadal failure
consequent uponpituitary oreven other general diseases is frequently as-
sociatedwith alteredfunctionofotherendocrineglands (e.g., the adrenal
cortexorthyroid). Insuchcases analtered 17-ketosteroidexcretion could
notaccurately reflectthefunctional status of the interstitial cell elements
of the testis, since adrenal and even thyroid disorders may profoundly
alter the excretion of steroids (see later discussion). Normally one-third
of the 17-ketosteroids is derived from the male gonad and two-thirds
from the adrenal cortex. Aslight increase in the elaboration of androgen
by the adrenal, or in some cases no change in adrenal cortical function,
could lead to levels of steroid excretion that are well within the normal
range in spite of failure of elaboration of gonadal androgen. Hence, a
normal value would not rule out failure of androgen elaboration by the
testicle nor would a low value prove a primary gonadal failure. Since
puberty is not reached until the sixteenth year in some normal boys, a
diagnosis of "hypogonadism" or "eunuchoidism" is difficult before this
age. If one determines the 17-ketosteroid excretions in patients with
clinically evident testicular failure, regardless of the genesis of the con-
dition, values will be obtained which will range from below normal
to high normal. For example, Werner243 reported values ranging from
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2.6 mg. to 14.6 mg. in 16 "eunuchoid" patients; two-thirds of the
patients excreted amounts within his range of normal (7 to 17 mg. per
24 hours). These results may be considered to be representative. Clearly,
every patient that reveals evidences of testicular failure (regression or
lack of development of secondary sexual characters, lack of libido,
impotence, testicular atrophy) must be studied individually and no
single hormone assay can be relied upon uniformly to indicate the
origin of the disorder.
Acromegaly. It is interesting to note in Table 15 that of 15 cases
ofacromegaly,probably 5 andcertainly 3 showedelevated 17-ketosteroid
excretions. However, usually the 17-ketosteroid excretion was normal
and occasionally even slightly below normal. Eosinophilic adenomas of
thepituitary with acromegaly are frequently associated with pathological
lesions of other endocrine glands.131 Nodular or diffuse goiter, hyper-
plasia of the parathyroids or thymus, degenerations of the pancreatic
islet cells, adrenal cortical hyperplasia, and various degrees of degenera-
tive change in the male and female gonads have been described. Un-
fortunately, clinical and pathological data are not available on the above
15 cases of acromegaly in whom steroid excretions were measured.
It is notpossible to form any opinion as to the genesis or significance of
the reportedly high or low values.
Conditions associated with decreased amounts of steroids in urine
In Tables 8, 9, and 15 are listed various clinical states associated
with low 17-ketosteroid and "corticosteroid" excretions. Since these
steroids are mainly derived from the adrenal cortex and since normal
adrenal cortical function cannotexist in the presence of anterior pituitary
failure, itwould beexpected that the excretion of these substances would
be diminished in conditions associated with destruction or atrophy of
the adrenal cortex or pituitary. It is noted in Table 15 that consistently
low values for the 17-ketosteroid excretion are observed in patients
with Addison's disease and also in those with anterior pituitary in-
sufficiency; values below 1 mg. per 24 hours are frequently seen. Since
a small portion of these steroids is derived from the male gonad, the
lowest values areobserved in female patients with Addison's disease and
in patients with destruction of the pituitary. There is some discrepancy
in the results reported by different investigators, e.g., Fraser et al.
consistently obtained lower values than did Callow or Venning et al.
These variations are due to slight differences in the technics employed
in performing the chemical assay. Fraser and co-workers used the
technic of Callow but compensated for the presence of interfering
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Table 15
SOME REPRESENTATIVE DATA CONCERNING THE 17-KETOSTEROID EXCRETION IN ACRONfMEGALY, ANTERIOR PITUITARY INSUFFICIENCY, MYXEDEMA, ADDISON'S DISEASE AND ANOREXIA NERVOSA
17-ketostroid
excretion in mgm.
per 24 howr
Remarks
1. Acromegaly ( 15 cases)
Fraser et al.,73 case 59 2.9 (av.)
Fraser et al.,73 case 62 3.6 (av.)
Fraser et al.,73 case 58 4.5 (av.)
Fraser et al.,73 case 63 8.3 (av.)
Fraser et al.,73 case 61 10.2 (av.)
Fraser eta.,73 case 60 10.6 (av.)
Venning et al.,232 case 23 11.8
Venning et al.,232 case 22 12.7
Warren,239 case 138 15.1
Warren,239 case 132 20.4
Venning et al.,232 case 24 24.0, 26.3
Venning et al.,232 case 25 28.6, 37.6
Warren,239 case 110 38.6
Scowen and Warren203 70.0
Scowen and Warren203 110.0
Il. Anterior Pituitary Insufficiency (35 cases)
Fraser et al.,73 15 cases Range 0.5-2.8
Fraser and Smith,74 10 cases Range 0.0-1.5
Venning and Browne,232 5 cases Range 1.4-4.5
Friedgood,75 5 cases 0.5-2.5
Female, age43, symptoms 15 yrs.
Female, age 41
Female, age 28, symptoms 1 yr.
Male, age 31, symptoms 10 yrs.
Female, age 35, symptoms 10 yrs.
Female, age 36, symptoms 3+ yrs.
Female, age 32, symptoms 3 yrs.
Female, age 54, symptoms 15 yrs.
Female, age 26, "early acromegaly."
Female, age 30, "acromegalic."
Male, age 39, symptoms 14+ yrs.
Male, age 28, symptoms 2 yrs.
Male, age 34, "acromegaly."
Female, age ?, "acromegaly."
Male, age ?, "acromegaly."
13 of the 15 averaged less than 0.5 mgm.
9 of the 10 cases gave zero values.
III. Myxedema: Spontaneous (21 cases)
Fraser et al.,73 4 cases Range 0.6-1.6 All females
Fraser and Smith,74 3 cases Range 0.0-1.7 All females
Engstrom and Mason,62 6 cases Range 1.2-3.3 5 females, 1 male
Friedgood,75 8 cases Range 0.0-2.3 All females
Myxedema: Secondary to thyroidectomy or thyroiditis (9 cases)
Engstrom and Mason,62 4 cases Range 2.5-6.7 3 females, 1 male (17-KS, 67)
Friedgood,75 5 cases Range 1.7-5.8 All females
V. Addison's Disease: Females
Fraser et al.,73 5 cases
Venning et al.,232 3 cases
Friedgood,75 2 cases
Callow et al.'
Addison's Disease: Males (
Fraser et al.,73 3 cases
Venning et al.,232 1 case
Friedgood,75 3 cases
Callow et al.,38 3 cases
(14 cases)
Range 0.5 (all cases)
Range 1.9-6.8
Average 1.0
Range 3.1-7.5
'10 cases)
Range 2.1-3.5
Range 2.3-3.8
Range 0.0-3.0
Range 3.5-7.5
V. Anorexia Nervosa (severe, chronic malnutrition): all females (12 cases)
Fraser et al.,73 5 cases Range 2.3- 7.2 (Ages 20-31)
Fraser and Smith,74 4 cases Range 2.7-14.7 (Ages 20-27)
Venning and Browne,2323cases Range 3.5- 7.2 (Ages 24-;7)
Asdihor and case
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chromogens by using a correction factor. Callow recognized that many
of his values were "too high" since atypical colors developed in certain
crude extracts. Venning et al. applied a correction equation to the
aqueous-alcohol technic of Holtorff and Koch'04 and hence higher
values would be expected to result.62 Engstrom and Mason employed
the method of Fraser et al. These differences in technic are not readily
apparent when dealing with values that are within or above the normal.
adult levels but become obvious when dealing with low levels of
steroid excretion.
States of severe, chronic malnutrition as seen in anorexia nervosa
resemble anterior pituitary insufficiency in many physiological respects,
e.g., anorexia,weakness,hypometabolism,146 cessationofnormalgonadal
function,24 diminution of the usual alimentary hyperglycemia induced
by ingestion of carbohydrate,194' 207 etc. There is experimental evidence
that inanition leads to lowered gonadotropic and adrenocorticotropic
activity of the anterior pituitary.'60 167, 169 As might be anticipated the
17-ketosteroid excretion isdiminishedin anorexia nervosa, butingeneral
the observed values are not so low as those seen in patients with grossly
destructive pituitary lesions. A functional pituitary insufficiency as a
physiologic response to the abnormal nutritional state has been sug-
gested as the most likely cause of many of the observed phenomena in
anorexia nervosa.169 207
The observation that myxedema, spontaneous or secondary, is as-
sociated with extremely low levels of 17-ketosteroids is a curious
finding and the mechanism of this association has not been elucidated.
A low "corticosteroid" excretion also has been reported.216 In Table 15
it is noted that the steroid excretion is very low (frequently below 2
mg.) andcomparable in amount to thatseen inpatients with deficiencies
of pituitary or adrenal cortical secretions. The myxedematous state is a
profound, generalized metabolic disturbance and it is conceivable that
adrenal cortical function could be sufficiently altered, as a part of the
general disorder, so that a deficiency of steroid elaboration would re-
sult. If this were the case replacement therapy with desiccated thyroid
should restore the excretion of steroids to normal levels. This seems
to have occurred in a few cases of secondary myxedema (i.e., myxedema
following thyroidectomy or thyroiditis) whose symptoms were of
short duration;62 however, replacement therapy has not been shown
definitely toalterthe low levelsofexcretion inpatients with spontaneous
myxedema or with secondary myxedema of long duration.62 75 To
explain adequately thisphenomenon would necessitate an understanding
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of the pathogenesis of spontaneous myxedema and an understanding of
many subtle effects of chronic deficiency of the thyroid hormone on the
pituitary and other tissues. A theoretical consideration of some of these
factors is reviewed by Engstrom and Mason,62 and by Friedgood.7"
A variety of chronic illnesses (the postoperative state, infections,
diabetes,thyrotoxicosis, sprue, etc.) usually leads to amoderate lowering
of the 17-ketosteroid excretion.68' 7 No explanation thus far offered
has been entirely satisfactory. The decreased excretion of these steroids
may be related to an associated starvation and the mechanisms of its
development may be similar to those involved in more severe states
of malnutrition (e.g., anorexia nervosa). Albright and his associates68
have suggested a diminished androgen production by the adrenal cortex
as a manifestation of the "adaptation phenomenon" of Selye.205 How-
ever, it is still possible that the precursors of these urinary steroids are
elaborated at a normal or even at an increased rate during chronic
stresses, but their transformations are diverted to channels other than
theurinary 17-ketosteroids. Withoutmore information on theutilization
of steroids and on the factors concerned with their transformation and
excretion it is premature to imply that increased or decreased steroid
excretion, respectively, means increased or decreased elaboration of
precursor steroids under all circumstances.
Summary
In this review the nature and amounts of the neutral steroid sub-
stances found in urine in certain abnormal clinical states are summarized
from the literature through 1947. To appraise the significance of
these data necessitated a brief, preliminary consideration of a variety of
biochemical data and biological concepts. The chemical nature, bio-
logical actions, and possible transformations of the adrenal cortical and
testicular hormones were considered so far as this was possible for
man. Anumberof factors (environmental, nutritional, nervous, genetic,
and maturity) normally appear to be concerned with the control of the
extent of elaboration of hormones. In certain instances the same factors
appear to influence the nature of the biological response to hormones.
Although data would indicate that the neutral urinary steroids arise
from hormones elaborated by the adrenal cortex and gonads, it is ap-
parent that little is known concerning the factors which influence the
transformations of precursor steroids to excretory products in man. It
is not known whether the transformations that occur are concerned
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with hormone utilization or inactivation. In view of the uncertainties
involved, little effort was made, except in a few instances, to interpret
the genesis ofcertain clinical states in terms of the known actions of the
adrenal or gonadal hormones or in terms of the levels of excretion of
steroids. What efforts were made in this regard, were made to point
out the variables involved in such considerations. Most emphasis has
been placed on the variableness of the quantities of and on the nature of
the excreted steroids encountered in different individuals with similar
clinical conditions and on the biological factors which might cause
differences in results indifferentclinical states. Only with this knowledge
can methods of assay be utilized and applied as diagnostic or investiga
tive tools.
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